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AF4    Asymmetric flow field flow fractionation 
AO    Atomic orbital 
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CC    Correlation coefficient 
CCP4   Collaborative Computational Project No. 4 
CV    Column volume 
Da    Dalton 
DLS    Dynamic light scattering 
DTT    Dithiotheritol 
EHEC   Enterohemorrhagic E. coli 
EM    Electron microscopy 
EPEC   Enteropathogenic E. coli 
Flh    Flagellar homolog 
GPC    Gel permeation chromatography 
GST    Glutathione S-transferase 
HMQC   Heteronuclear multiple quantum coherence 
HRP    Horse radish peroxidase 
IEC    Ion exchange chromatography 
IPTG   Isopropyl-β-D-thiogalactoside 
LCAO   Linear combination of atomic orbitals 
MAD    Multiple wave length anomalous dipersion 
MO    Molecular orbital 
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MR    Molecular Replacement 
MWCO   Molecular weight cut off  
NMR   Nuclear magnetic resonance 
ODλ    Optical density at wavelength λ 
PCR    Polymerase chain reaction 
PDB    Protein Data Bank 
pI    Isoelectric point 
Rh    Hydrodynamic radius 
r.m.s.d.   Root mean square diviation 
rpm    Rounds per minute 
SDS    Sodium dodecyl sulphate 
SDS-PAGE  SDS-polyacryalmid gel electrophoresis 
SeMet   Selenomethione 
SLS    Static light scattering 
STEM   Scanning transmission electron microscopy 
TCEP   Tris(2-carboxyethyl)phosphine 
TxS    Type x secretion 
TxSS   Type x secretion system 
Ve    Elution volume 
VM    Matthews coefficient 
Y.    Yersinia 
Yop    Yersinia outer protein 
Ysc    Yersinia secretion 
YscUC   Yersinia secretion protein U (aa 211-354) 
YscVC   Yersinia secretion protein V (aa 322-704) 
YscVC356   Yersinia secretion protein V (aa 356-704) 
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Zusammenfassung 
Das intestinale Pathogen Yersinia enterocolitica verwendet für den Transport von 
Effektoren über die eukariotischen Zellmembranen eine hoch entwickelte 
Injektionsmaschine, die auch als injectisome oder Typ III Sekretions System (T3SS) 
bezeichnet wird. Sobald das Pathogen mit einer eukaryotischen Wirtszelle, z.B. einer 
Makrophage, in Kontakt tritt, wird durch das injectisome eine Reihe von Effektoren in 
diese geschleust. Dort greifen die Effektoren in die zellulären Funktionen der 
Makrophage ein, sodass diese nicht mehr in der Lage ist das Pathogen zu 
phagozytieren. Die hochkomplexe molekulare Struktur des T3SS, welche auch in 
anderen Gram-negativen Pathogenen wie Salmonella spp., Shigella spp. und 
enteropathogenen Escherichia coli zu finden ist, ist evolutionär mit dem bakteriellen 
Flagellum verwandt, welches den Proteinexportkanal für den Aufbau seiner äußeren 
Komponenten nutzt. Der Proteintransport selbst wird durch den Exportapparat, 
welcher aus den fünf konservierten integralen Membranproteinen YscR/S/T/U/V 
besteht, und dem ATPase System ermöglicht. Zwei der Membranproteine, YscU und 
YscV, besitzen größere cytoplasmatische Domänen, welche eine wichtige Rolle 
während des Proteinexports spielen. Daher sollen in dieser Arbeit die Strukturen 
dieser Domänen aufgeklärt und deren Funktionen im Exportprozess untersucht 
werden. 
Das in der inneren Membran lokalisierte Protein YscU spielt eine wichtige Rolle 
während des Aufbaus der äußeren Komponenten des injectisoms. Die 
cytoplasmatische Domäne von YscU (YscUC) erkennt poren- und spitzenbildende 
Proteine (Translokatoren) als spezifisches Substrat in der Exporthierarchie. Zur 
Aktivierung wird YscU in einem konservierten Aminosäuremotiv der Sequenz Asn-
Pro-Thr-His (NPTH) autokatalytisch gespalten. Modifikationen dieses Motivs 
verhindern die Spaltung von YscU, so dass die Translokatoren nicht mehr als 
Exportsubstrate erkannt werden und nicht mehr exportiert werden. Als Folge werden 
überdurchschnittlich lange Nadeln gebildet. Die Kristallstrukturen der nicht 
geschnittenen Varianten YscUC N263A und N263D wurden bei einer Auflösung von 
2.05 Å beziehungsweise 1.55 Å gelöst. Die globuläre Domäne des Proteins besteht 
aus einem zentralen, gemischten β-Faltblatt, das von α-Helices umgeben wird. Das 
NPTH Motiv bildet einen Typ II β-turn, der zwei benachbarte β-Stränge miteinander 
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verbindet. Die NMR Analyse von geschnittenem und ungeschnittenem YscUC zeigt, 
dass die globuläre Struktur des Proteins nach dem Schnitt erhalten bleibt. Die 
Struktur YscUC N263D erklärt warum in YscUC die Hauptkette aufgrund der optimalen 
Reaktionsgeometrie der Seitenkette des Asn263 über einen nukleophilen Angriff 
autokatalytisch gespalten werden kann. In vivo Analysen von YscU N263Q und 
H266A/R314A zeigen einen Phänotyp, bei dem der Transport von Translokatoren 
verhindert wird, aber normal lange Nadeln produziert. Ein Vergleich der Struktur von 
YscUC mit verwandten Proteinen zeigt, dass die Linkerdomäne, die sich zwischen 
der N-terminalen Transmembrandomäne und der autokatalytischen Domäne 
befindet, eine gestreckte bzw. eine größtenteils α-helikale Konformation einnehmen 
kann. Dies erlaubt vermutlich eine optimale Platzierung der selbst schneidenden 
Domäne während des Exportprozesses. 
Das integrale Membranprotein YscV ist die größte Komponente innerhalb des Typ III 
Sekretions Apparates. Ähnlich wie YscU besteht YscV aus einer N-terminalen 
Transmembrandomäne und einer C-terminalen cytoplasmatischen Domäne. Für das 
flagellare Homolog FlhA konnte gezeigt werden, dass die cytoplasmatische Domäne 
(FlhAC) mit FlhBC (YscUC), der ATPase und dem ATPase Regulator interagiert. Daher 
wird angenommen, dass YscVC zusammen mit YscUC eine Ankopplungsstelle für den 
ATPase-Substrat Komplex bildet. Limitierte Proteolyseuntersuchungen zeigen, dass 
YscVC aus einer Linkerregion und einer globulären Domäne besteht. Desweiteren 
konnte ein Reinigungsschema, das ausreichende Mengen an sauberem Protein 
liefert, etabliert werden. Obwohl YscVC und die kürzere Variante YscVC356 unter einer 
Vielzahl von Bedingungen kristallisierte, war eine Röntgenstrukturanalyse aufgrund 
der schlechten Kristallqualität bisher nicht möglich. 
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Summary 
The enteric pathogen Yersinia enterocolitica uses a sophisticated injection machinery 
called an injectisome or type III secretion system (T3SS) to translocate effector 
proteins across eukaryotic cell membranes. Upon contact with the eukaryotic host 
cell, e.g. a macrophage, a set of effector proteins is translocated into the 
macrophage’s cytoplasm. There the effectors subvert macrophage cellular functions 
to inhibit phagocytosis of the pathogen. The supramolecular structure of the T3SS, 
found in many Gram-negative pathogenic or symbiotic bacteria including Salmonella 
spp., Shigella spp. and enteropathogenic Escherichia coli is evolutionarily related to 
the bacterial flagellum, which uses the export channel for assembling of its outer 
components. The protein export itself is managed by the export apparatus, consisting 
of five conserved integral membrane proteins YscR/S/T/U/V, and the ATPase system. 
Two of the integral membrane proteins, YscU and YscV, consist of large cytoplasmic 
domains that play an important role during the export process. Within this thesis the 
structures of these domains should be determined and their function within the export 
process should be analyzed. 
The inner-membrane protein YscU plays an important role during the assembly of the 
outer components of the injectisome. Its cytoplasmic domain (YscUC) recognizes tip- 
and pore-forming proteins (translocators) as individual substrates in the export 
hierarchy. Activation of YscU entails autocleavage at a conserved amino acid 
sequence Asn-Pro-Thr-His (NPTH) motif. Modification of this motif markedly changes 
the properties of YscU including cessation of translocator export and production of 
longer injectisome needles. The crystal structures of the uncleaved variants N263A 
and N263D of YscUC were determined at 2.05 Å and 1.55 Å resolution, respectively. 
The globular domain is found to consist of a central mixed β-sheet surrounded by α-
helices. The NPTH motif forms a type II β-turn connecting two β-strands. NMR 
analysis of cleaved and uncleaved YscUC indicates that the global structure of the 
protein is retained in cleaved YscUC. The structure of YscUC variant N263D reveals 
that wild-type YscUC is poised for cleavage due to an optimal reaction geometry for 
nucleophilic attack of the scissile bond by the side-chain of Asn263. In vivo analysis 
of N263Q and H266A/R314A YscU variants showed a phenotype that combines the 
absence of translocator secretion with normal needle-length control. Comparing the 
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structure of YscU to those of related proteins reveals that the linker domain between 
the N-terminal transmembrane domain and the autocleavage domain can switch from 
an extended to a largely α-helical conformation, allowing for optimal positioning of the 
autocleavage domain during the export process. 
The integral membrane protein YscV is the largest component within the type III 
secretion apparatus. Similar to YscU, YscV consists of an N-terminal transmembrane 
part and a C-terminal cytoplasmic part. The cytoplasmic part of the homologues 
flagellar protein FlhAC has been shown to interact with FlhBC (YscUC) as well as the 
ATPase and its regulator. Thus it has been proposed that YscVC and YscUC together 
form a platform for docking the ATPase-substrate complex. Limited proteolysis 
showed that YscVC consists of a linker region and a globular cytoplasmic domain. 
Furthermore, expression and a purification scheme were established yielding pure 
and sufficient amounts of protein. Although YscVC and its shorter variant YscVC356 
crystallize in various conditions, as yet an X-ray analysis was not possible due to 
poor crystal quality.  
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1 Introduction 
The World Health Organisation (WHO) monitors the worldwide (re)emergence of 
bacterial pathogens causing foodborne diseases (WHO, Fact sheet No 124). The 
most common pathogens inflicted in these diseases are Yersinia enterocolitica, 
Salmonella spp., Vibrio cholerae, Listeria monocytogenes and pathogenic E. coli. In 
Germany over 200,000 cases of disease per year are reported to be caused by 
consumption of contaminated food (Bundesinstiut für Riskobewertung, Germany). 
New foodborne disease threats occur for a number of reasons. These include a 
steady increase in international travel and trade, pathogen resistance against 
antibiotics, changes in food production process, as well as human demographics and 
behaviour. Therefore an understanding of bacterial pathogenesis is important for 
developing new antibiotics and strategies against these diseases.  
 
1.1 Yersinia - one of the most dangerous pathogens 
The genus Yersinia is a coccobacillus-shaped Gram-negative bacterium, which 
belongs to the family of Enterobacteriaceae. Eleven different species are known of 
which three are pathogenic for humans: Yersina pestis and the two enteropathogenic 
species Yersinia pseudotuberculosis and Yersinia enterocolitica (Bergsbaken & 
Cookson, 2009; Wren, 2003).  
Yersinia enterocolitica is one of the most common cause of foodborne 
gastrointestinal diseases, whereas Yersinia pseudotuberculosis is primarily an animal 
pathogen that rarely causes diseases in humans (Trulzsch et al., 2007). Both species 
are found widely in the environment and cause infection (Figure 1), after the 
consumption of contaminated food or water (Wren, 2003). Once the bacteria reach 
the small intestine, they enforce their uptake into M cells by several non-fimbrial 
adhesins such as invasin and the Yersina adhesion A (YadA) (Dersch, 2003; Isberg & 
Barnes, 2001; Trulzsch et al., 2007). Both of these proteins interact with β 1 integrins 
of eukaryotic cells and are believed to mediate adherence and invasion of M cells 
(Isberg & Barnes, 2001). After penetrating the intestinal epithelium, the bacteria are 
transcytosed into Peyer´s patches and migrate to the mesenteric lymph nodes. 
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Subsequently, the bacteria colonize liver and spleen, where they replicate externally 
(Wren, 2003). As a consequence, a rapid inflammation ensues and the disease may 
manifest in enteritis, terminal ileitis, or mesenteric lymphadenitis with watery or 
sometimes bloody diarrhoea (Trulzsch et al., 2007). The collective form of the 
different symptoms is also called yersiniosis.  
 
Figure 1: Path of infection of Yersinia spp. Plague is caused either by a flea bite or respiratory 
droplets from humans. In contrast, the yersiniose is caused by the uptake contaminated food or water 
(Wren, 2003). 
 
The most known species Y. pestis is the causative agent of plague, which has killed 
millions of people during three large pandemics: the Justinian plague (5th-7th 
centuries), the mediaeval Black Death (13th-15th centuries) and the modern plague 
(1870s to present) (Perry & Fetherston, 1997). Although Y. pestis evolved from Y. 
pseudotuberculosis just 1,500-20,000 years ago (Achtman et al., 1999), it has 
developed a markedly different infection pathway compared to its enteropathogenic 
relatives (Figure 1). Y. pestis established a transmission way to non infected 
mammalian reservoirs (primarily rodents) using fleas as carrier. Due to additional flea 
plasmids, Y. pestis is able to survive in flea and is successfully transmitted during the 
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next bite into the mammalian host (Perry & Fetherston, 1997; Wren, 2003). 
Occasionally, the bacteria are injected into a human body, where they can enter the 
lymphatic system and cause a haemorrhaging inflammation. The resulting 
characteristic painfully swollen lymph nodes (bubo) are associated with this disease 
(bubonic plague) (Bergsbaken & Cookson, 2009; Rollins et al., 2003). From the 
lymphatic system the bacteria can enter the bloodstream, which distributes them 
through the whole body. In the following septicemic plague, bacterial endotoxins 
cause disseminated intraveascular coagulations (clots) resulting in necrosis. The 
infection can also progress with the bloodstream to the lung, causing the highly 
infectious pneumonic plague, which allows spread from person-to-person through 
respiratory droplets (Wren, 2003). If the plague is not treated with antibiotics on time, 
the mortality rate is close to 100% (Prentice & Rahalison, 2007). Due to a better 
hygiene and effective antibiotics, the plague is not a common health problem today. 
 
1.2 The pVY plasmid is necessary for Yersina´s virulence 
The first line of defence in humans against invading bacterial pathogens is the innate 
immune system. Bacteria possess so-called pathogen-associated molecular patterns 
(PAMPs) which are recognised by specific sensor proteins (pattern-recognition 
receptor, PRR) on the surface of immune cells. Upon detection the innate immune 
system activates macrophages and dendritic cells, which in turn take up the 
pathogens by phagocytosis and induce inflammation by releasing cytokines. 
Furthermore, activation of the innate immune system also set off the adaptive 
immune system finally to eradicate the infection (Shao, 2008). However, all three 
pathogenic Yersinia spp. seems to be largely untouched from this immune defence 
machinery. Genetic studies revealed that pathogenic Yersinia carry an extra 70 kbp 
plasmid, pVY, which encodes specific effectors and a type III secretion system 
(T3SS). The T3SS enables the bacteria to inject the effectors into the host cell and 
thus overcome the immune defence machinery (Cornelis et al., 1998; Wren, 2003). 
Several other Gram-negative bacteria, like Salmonella, Shigella and 
enteropathogenic Escherichia coli, use the same nano machinery also for their 
infection (Cornelis, 2006).  
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1.3 Yersinia outer proteins prevent phagoytosis  
During infection Yersinia´s T3SS delivers at least six effector proteins, which are 
known as Yops (Yersina outer proteins), into the host´s cytoplasm. These Yops work 
efficiently together and prevent host phagocytosis by inducing macrophage cell 
death. Further, the production of cytokines is suppressed, which leads to reduced 
inflammation and immune response (Shao, 2008; Trosky et al., 2008).  
 
Figure 2: Targets of the six Yop effectors in the host cells. YopE, YopO, YopT and YopH interfere 
in the regulation of the actin cytoskeleton, which efficiently prevents phagocytosis. YopM and YopP 
contribute to transcriptional inhibition of immune response genes, whereas the exact role of YopM 
remains elusive (Shao, 2008). 
The major function of YopE, YopT and YopO (YpkA in Y. pestis and Y. 
pseudotuberulosis) is the disassembly of actin filaments (Navarro et al., 2007; Von 
Pawel-Rammingen et al., 2000). They inactivate members of the family of Rho 
GTPases by modulating the GTP/GDP-bound states (YopE and YopO) or detach Rho 
GTPases from the membrane (YopT) by cleaving off the membrane anchor (Shao et 
al., 2003). YopO also blocks signalling pathways of G-proteins by phosphorylation of 
the Gαq subunit (Navarro et al., 2007). The tyrosine phosphatase YopH functions as 
an antiphagocytic effector by dephosphorylating several components of the focal 
adhesion complex and thus preventing actin polymerisation (Viboud & Bliska, 2005). 
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MAPK (mitogen activated protein kinase) and NF-κB (nuclear factor- κB) pathways 
are down-regulated by the YopP (YopJ in Y. pestis and Y.pseudotuberulosis) 
catalysed acetylation of MAPK kinases and IKKs (IκB kinase), which results in a 
suppression of cytokine production (Ruckdeschel et al., 2001). The role of YopM is 
still unclear, as effects on gene transcription revealed only contradicting results 
(Trosky et al., 2008). However, in vitro assays showed that the two cellular kinases 
protein kinase C-like 2 (PRK2) and ribosomal S6 protein kinase (RSK1) act as 
binding partners for YopM (McDonald et al., 2003). Although the kinases’ activities 
are stimulated by binding, there is no evidence that these kinases interact during 
normal cellular activities (Shao, 2008).  
 
1.4 Bacterial secretion systems  
Secretion is an essential process for bacteria to modulate their environment, 
especially, if they interact with other organisms as symbionts or pathogens. For this 
purpose, bacteria have evolved a variety of molecular machineries that transport 
cargoes such as proteins, DNA and drugs across the bacterial membrane(s) and in 
some cases even across the host cell membrane. As yet, six different types of 
secretion systems (T1SS-T6SS) are known in Gram-negative bacteria (Figure 3). 
Gram-positive bacteria share some of these secretion systems and display 
additionally the Gram-positive specific T7SS (Tseng et al., 2009). 
The T1SS transport proteins of diverse sizes (10-900 kDa) and functions in a single 
step over both bacterial membranes (Wooldridge, 2009). Thereby secretion usually 
depends on the presence of a specific C-terminal secretion signal. Many of the 
exported proteins are important for bacterial pathogenesis. The machine is made up 
of only three proteins: an ATPase binding cassette (ABC) transporter, an outer 
membrane factor (OMF) and a membrane fusion protein (MFP). T1SS also exports 
non-proteinaceous substrates such as cyclic β-glucans and polysaccharides 
(Delepelaire, 2004). 
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Figure 3: Schematic representation of the known bacterial secretion systems. HM, host 
membrane; OM, outer membrane; IM, inner membrane; MM; mycomembrane; OMP, outer membrane 
protein; MFP, membrane fusion protein (Tseng et al., 2009). 
 
Translocation via T2SS and T5SS requires at least two steps. At first substrates are 
exported into the periplasm by the universal Sec or two-arginine (Tat) pathways and 
then translocated across the outer membranes. Both systems are required for export 
of several virulence factors. The T2SS is composed of 12 to 16 Gsp (General 
secretion pathway) proteins, which build a large structure (secreton) that spans the 
whole periplasm and is thought to connect the inner and outer membrane (Cianciotto, 
2005). The T5SSs are divided into three sub-classes (T5aSS-T5cSS). All possess an 
outer membrane β-barrel protein domain, through which secretion of effector 
molecules is achieved (Henderson et al., 2004). The autotransporters (T5aSS) and 
the trimeric autotransporters (T5cSS) consist of an additional N-terminal passenger 
domain (40-400 kDa) that is exported into the extra-cellular space. In some case, 
such as the adhesion protein YadA from Y. enterocolitica, the passenger domain 
remains attached to the transporter. In other cases domains are cleaved off from the 
transporter and build enzymes or toxins. In the two partner secretion system (T5bSS) 
effector and translocator are synthesized as separate proteins that associate in the 
periplasm (Henderson et al., 2004). 
T3SS (discussed below), T4SS and T6SS translocate their substrates at least over 
three membranes directly into their host cells, therefore constituting virulence 
determinants. In comparison to the other secretion systems, the T4SS has the ability 
to transport DNA or protein/DNA complexes. Agrobacterium tumefaciens uses the 
machinery to inject tumor inducing plamids (Ti-plasmid) into the host cell. The 
resulting crown gall tumors produce opines (amine derivatives of amino acids and 
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sugars), which serve as a carbon source for the pathogen (Tseng et al., 2009). The 
overall architecture can be divided into a pilus and a core complex, which spans both 
membranes. The entire core complex (1.05 MDa) consists of multiple copies of three 
proteins. Recently, the crystal structure of the outer membrane channel (~0.6 MDa) 
has been determined at atomic resolution (Chandran et al., 2009). Transport energy 
is provided by three ATPases, which are anchored in the inner membrane (Chandran 
et al., 2009; Fronzes et al., 2009). The T6S machinery has been recently 
characterized and appears to constitute a phage-tail spike-like injectisome that 
induces its effectors directly into the host´s cytoplasm. A model has been proposed 
that includes a cytoplasmic chaperone with ATPase activity, a channel bridging both 
membranes and a needle that is topped by a pore structure (Shrivastava & Mande, 
2008). 
The T7SS is a specialized secretion system for Gram-positive bacteria like 
mycobacteria. In these bacteria substrates also have to be transport across the 
bacterial cell wall (mycomembrane), as it is heavily modified with lipids (Tseng et al., 
2009). Structure and function of the system are still poorly understood, but a first 
model suggests the presence of channels in both membranes. The effector 
substrates are bound to chaperone-like ATPases and exported invariably as 
heterodimers (Abdallah et al., 2007). 
 
1.5 Type III secretion system and flagellum are related 
To inhibit phagocytosis, Yops have to be transported into macrophage by Yersinia. 
For this purpose, they are equipped with a T3SS, which is also called injectisome as 
it works like a molecular syringe. The T3SS consists of the injectisome apparatus 
itself, secreted proteins (translocators and effectors), chaperones and cytoplasmic 
regulators. About 25 Yop secretion (Ysc) proteins are required to build up this 
injection machinery (Cornelis, 2006). Nine of these Ysc proteins (YscC, J, N, Q, R, S, 
T, U, V) are highly conserved among the seven known injectisome families. Eight of 
them, in turn, share significant similarity with components of the flagellum, which is 
obvious by the overall structural similarity of T3SS and flagellum (Figure 4). 
Phylogenetic studies also suggest that injectisome and flagellum derive from a 
common ancestor (Gophna et al., 2003; Pallen et al., 2005; Troisfontaines & 
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Cornelis, 2005). The flagellar system uses T3S for sequential export of its outer 
components (rod, hook and filament). Under special conditions, the flagellar system 
has the ability to also export non-flagellar proteins (Young et al., 1999). 
 
Figure 4: Schematic representation of the flagellum and the Yersinia injectisome. IM, inner 
membrane; OM, outer membrane; PG, peptidoglycan. The C-ring of the Yersinia injectisome is 
represented in dashed lines as information on this component is still scarce (Cornelis, 2006). 
 
1.6 Architecture of the injectisome 
As it is difficult to orientate in between the different T3SS proteins and their 
homologs, a pull-out page can be found at the end of the thesis (see appendix Figure 
55). It contains a schematic drawing and sizes of the Yersinia type III secretion 
system. Further, it provides an overview on several Yersinia proteins and their 
homologues variants, which are discussed here.  
Although some parts of the injectisome still remain elusive, considerable progress in 
structural information has been made to get insights into structure and function of the 
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T3SS. The molecular architecture can be roughly dived into an external part, a 
membrane embedded basal body, which harbors also the T3S apparatus, an ATPase 
complex and a proposed C-ring attached to the basal body (Cornelis, 2006) (Figure 
4). 
 
Needle, tip and pore 
Depending on the injectisome the basal body is topped by a needle (Blocker et al., 
1999; Hoiczyk & Blobel, 2001; Kubori et al., 1998; Marlovits et al., 2004), a filament 
(Van Gijsegem et al., 2000) or a pilus (Crepin et al., 2005; Daniell et al., 2001; 
Knutton et al., 1998). In Y. enterocolitica (strain E40, Figure 5 A and B) the 
injectisome is equipped with a 65 ± 10 nm long hollow stiff needle (Journet et al., 
2003) (needle length varies from 49 ± 6 nm to 87  ± 11 nm for different strains 
(Wagner et al., 2009)), which is helically polymerised by the protein YscF. The helical 
parameters (5.6 units per turn, 2.4 nm helical pitch) are very similar to the flagellar 
hook, although the needle subunits (~ 9kDa) are significantly smaller than the hook 
subunits (~40 kDa) (Cordes et al., 2005). At the upper end the needle is terminated 
by a pentameric tip complex (Figure 5 A), which is made up of translocator protein 
LcrV. It is suggested that the tip complex serves as a scaffold or assembly platform 
for the translocation platform, which is made up of the translocators YopB and YopD 
(Mueller et al., 2005). 
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Figure 5: Structural components of the T3SS. (A) Projection average (top) of STEM images of the 
tip complex and transmission electron micrograph of Y. enterocolitica with a protruding needle 
(Cornelis, 2006). (B) Molecular model of T3S needle from Shigella flexneri (PDB accession number: 
2V6L (Deane et al., 2006)). (C) Cutaway view of the needle complex of Salmonella obtained from 
cryo-EM (EmDep accession number 1224 (Marlovits & Stebbins, 2010)). 
 
Basal body and C-ring 
Three dimensional reconstruction of single particle cryo-EM of the needle complexes 
from Salmonella (Marlovits et al., 2004) and Shigella (Hodgkinson et al., 2009) 
provided a detailed view on the basal body and the needle base (Figure 5 C). The 
basal body is made up of several rings, which are embedded in the outer and inner 
membrane and connected by a central rod. A cutaway view of the Salmonella 
complex showed an inner channel (Ø ~ 2-3 nm) which is anchored to a socket-like 
structure and traverses the whole chamber of the needle complex (Marlovits & 
Stebbins, 2010). Analysis of the basal body revealed that the scaffold is made up of 
only three proteins, which are called in the Yersinia system YscC, D and J (Galan & 
Wolf-Watz, 2006; Spreter et al., 2009). The outer membrane rings are formed by 12 
to 14 of YscC monomers that belong to the secretin family (Blocker et al., 2001; 
Burghout et al., 2004b; Koster et al., 1997; Tamano et al., 2000). For proper 
membrane insertion the assistance of lipoproteins (YscW family) is required 
(Burghout et al., 2004a). The inner membrane rings are proposed to be built by two 
proteins, which belong to the conserved lipoprotein family YscJ and the less 
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conserved family YscD (Spreter et al., 2009). The crystal structure of the periplasmic 
domain of EscJ (Yip et al., 2005), the EPEC ortholog of YscJ, allowed the modelling 
of a 24mer inner membrane ring, whereas YscD seems to be packed onto this ring 
(Spreter et al., 2009). Within the last years, several periplasmic domain structures of 
all three proteins were determined and revealed common ring building motifs 
documenting a close evolutionary relationship between the injectisomes (Marlovits & 
Stebbins, 2010; Spreter et al., 2009). 
Adjacent to the basal body a C(ytosolic)-ring, which is made up by the proteins of the 
YscQ family, has been proposed (Cornelis, 2006). However, up to now a C-ring was 
observed only in the flagellar system, in which it is an essential component of the 
rotation switch (Macnab, 2003). Furthermore, an interaction between the C-ring 
component FliN (flagellar C-ring consists of two proteins FliM and FliN) and FliI 
(ATPase) -FliH (ATPase regulator) complex suggested that the C-ring serves as a 
platform recruiting the ATPase complex (Gonzalez-Pedrajo et al., 2002).  
 
Export apparatus  
In the 3D reconstructed EM picture of the Salmonella basal body (Figure 5) a socket-
like structure, which is believed to anchor the inner rod, is found within the inner 
membrane ring. As it still unknown, which proteins build this structure, it is proposed 
to be made up of the export apparatus proteins, which build the translocation channel 
(Deane et al., 2010). However, this hypothesis remains to be verified. The export 
apparatus (Figure 6) itself is made up of five highly conserved trans-membrane 
proteins: YscR, -S, -T, -U and -V (Cornelis, 2006). Not much known is about YscR, -S 
and -T so far, the cytoplasmic domains of YscU and YscV (formally known as LcrD), 
however, are well investigated.  
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Figure 6: Proteins of the export apparatus. The orientation in the membrane of YscS and YscT still 
remains elusive. 
 
In YscU the cytoplasmic domain is autocleavable (Lavander et al., 2002) and is part 
of the substrate specificity switch (Sorg et al., 2007) discussed below. Furthermore, it 
has been shown that YscUC interacts with YscK (Docking of ATPase to the C-ring), 
YscL (ATPase regulator) and YscQ (proposed C-ring) (Riordan & Schneewind, 2008). 
The cytoplasmic domain of FlhA, the flagellar homologue of YscV, was shown to 
interact with FlhB (YscU), FlhI (ATPase) and Flh (ATPase regulator) and FliJ (general 
chaperone) indicating an important role during T3S (McMurry et al., 2004; Minamino 
et al., 2010). 
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Bioenergetics and the ATPase system 
For proper T3S an ATPase (YscN family) is required (Woestyn et al., 1994). YscN 
has been shown to interact with YscQ, YscK and YscL (Blaylock et al., 2006; Riordan 
& Schneewind, 2008), but so far it is not clear how the proteins work together. EM 
and X-ray analyses of HrcN (ATPase of Pseudomonas syringae) revealed a ring 
structure, which is formed by two hexameric rings stacked onto each other (Pozidis et 
al., 2003). Analysis of EscN (EPEC homologue) showed that the T3SS ATPases 
share similarity with the F1 ATPases, but structural and sequence differences 
indicate a unique role during secretion (Zarivach et al., 2007). The ATPase InvC from 
Salmonella enteric SPI-1 has been shown to bind and dissociate chaperone-effector 
complexes. Further, InvC unfolds effectors by spending ATP (Akeda & Galan, 2005). 
The unfolding activity seems to be crucial for energizing the secretion process, but a 
proton motive force has been found to be equally important for the export (Wilharm et 
al., 2004). So it has been suggested that the ATPase activity is needed for both 
substrate recruitment and unfolding. Possibly it also supports initial transfer into the 
export channel, but it is believed that the proton motive force provides the energy 
source for the export process.  
 
1.7 Assembly of the type III secretion system 
The assembly of the injectisome can be roughly divided into two steps: the formation 
of the basal body including the T3S apparatus and the formation of the outer 
components including the needle, tip and pore. The first stage, formation of the basal 
body, has not been investigated so far for the T3SS, instead the flagellar system is 
rather very well studied (Macnab, 2004). Following the flagellar assembly scheme it 
is believed that basal body formation is achieved by sequential insertion of the 
membrane components, for example the secretin, via the Sec pathway (Sorg et al., 
2007).  
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Figure 7: Assembly of the Yersinia injectisome: The ruler model. Once the basal body has been 
built completely, the T3S apparatus has to discriminate between different types of substrate. Early 
substrates such as needle subunits and the molecular ruler are transported until the needle has 
reached its final length. Then a switching event changes the substrate specificity to middle substrates, 
forming the tip and pore complex. Upon host cell contact a second switching event is triggered 
exporting the effectors into the host cell. HM, host cell membrane; OM, outer bacterial membrane; PG, 
peptido glycan layer; IM, inner bacterial membrane (Cornelis, 2006; Deane et al., 2010). 
 
Once the basal body has been inserted into the membrane, further components are 
transported by the T3SS in the second stage. Therefore the T3S apparatus has to 
discriminate between different export substrates. Needle assembly depends on the 
export of early substrates such as the needle subunits YscF and the length control 
protein YscP (Cornelis, 2006). How the needle length is controlled has been 
discussed intensely. Two models are currently discussed: the ruler/tape model 
(Yersinia) and the rod assembly model (Salmonella). The latter model suggestes that 
complementation of the inner rod terminates needle assembly by triggering the 
substrate specificity switch (Marlovits et al., 2006). In the ruler/tape model, needle 
length is tightly controlled by the so-called molecular ruler YscP. When the needle 
has reached its final length, YscP triggers the substrate specificity to intermediate 
(translocators) substrates (Cornelis, 2006). The second protein, which is thought be 
involved in this switching event, is the inner membrane protein YscU, which is likely 
to interact directly with YscP (Cornelis, 2006; Deane et al., 2010). Finally, late 
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substrates (effectors) are translocated into the host in a second switch event (Deane 
et al., 2010). 
 
1.8 The inner membrane proteins YscU and YscV 
As mentioned above, the highly conserved inner membrane proteins YscU and YscV 
are part of the T3S apparatus and comprise 354 (~40.3 kDa) and 704 (~77.8 kDa) 
amino acid residues, respectively. The exact localization of the proteins is not entirely 
clear. They might be part of the inner ring in the basal body (Deane et al., 2010). Both 
proteins share a similar domain architecture consisting of a N-terminal trans-
membrane region and a cytoplasmic domain (Saijo-Hamano et al., 2005; Sorg et al., 
2007). YscU and YscV are anchored into the membrane with four and six trans-
membrane helices and the cytoplasmic domains comprise amino acid residues 211-
354 (=YscUC) and 322-704 (=YscVC), respectively (Allaoui et al., 1994). The 
cytoplasmic domain of YscV seems to play an important role during the export 
process. The flagellar homologue FlhA was shown to interact with several 
components of the ATPase complex indicating a role in ATPase-complex recruitment. 
However, the mechanism of export is not clear yet. 
The cytoplasmic domain of YscU, which was originally found in the C-terminal 
cytoplasmic domain of the Salmonella flagellar YscU homolog, FlhB (Minamino & 
Macnab, 2000a), is cleaved autoproteolytically within a highly conserved NPTH motif 
(Lavander et al., 2003). It has been shown that autocleavage is crucial for secretion 
in both injectisome and flagellum. Abrogated autocleavage, which can be induced by 
substituting either Asn or Pro by Ala, leads to a poly-hook phenotype in the flagellum 
(Fraser et al., 2003) and longer and less regulated needles in the injectisome (Sorg 
et al., 2007). Further, there is no export of translocators (YopB, YopD and LcrV), 
whereas effectors are not affected. This lack of translocator export is due to a lack of 
recognition in non cleaved YscU indicating a role of YscU not only in the substrate 
specificity switch (see Chapter 1.7), but also during substrate recognition (Sorg et al., 
2007). Additionally, it was shown that cleaved GST-YscUC, purified from the Yersinia 
cytoplasm, bound to YscK/L/Q, also indicating a role in recruitment of the ATPase 
complex (Riordan & Schneewind, 2008). 
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2 Aim of this thesis 
In the current Yersinia export model, the T3SS has to discriminate between different 
substrate classes to assemble this complex molecular machinery. Therefore, the so-
called substrate specificity switch has been proposed to involve the “molecular ruler 
protein” YscP and the apparatus protein YscU. For proper function the cytoplasmic 
domain of YscU is cleaved autoproteolytically within a conserved NPTH motif. 
Bacterial mutants carrying a non-cleavable mutation no longer export translocator 
proteins, whereas export of effector proteins is not affected. Cleaved YscU thus 
appears to discriminate between translocator and effector proteins. As the cleavage 
event and the resulting structural changes might be important for the recognition of 
different export substrates, the structure of YscUC in its cleaved and uncleaved form 
was the first aim of this thesis. Furthermore, based on the structures, a detailed 
analysis of the autocleavage should reveal its functionality. 
Besides YscU, YscV also plays an essential role in T3S. Its flagellar homologue FlhA 
was shown to interact with several components: FlhB (YscU), FliI (ATPase), FliH 
(ATPase regulator) and FliJ (general chaperone). In the flagellar export model the 
cytoplasmic domains of FlhB and FlhA form a docking platform for the 
ATPase/substrate complex. Thus, the second aim of this thesis was the structural 
characterization of YscVC and biophysical analyses of potential interactions between 
YscUC and YscVC. 
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3 Materials and methods 
3.1 Standard materials 
Molecular-biological methods used in this work are adapted from standard collections 
of methods and protocols (Ausubel, 2007; Coligan, 2002; Sambrook, 2000). Only 
variations of standard protocols are described below. 
 
3.1.1 Chemicals, enzymes and antibodies 
All chemicals were purchased from the following companies, if not stated otherwise: 
Difco, Eurofins MWG Operon, Fermentas, Fluka, GE-Healthcare, Hampton 
Research, Invitrogen, Merck, Millipore, Qiagen, Riedel de Haen, Roche, Roth, 
Sigma-Aldrich and Stratagene. The quality standard was “pro analysis” (p.a.). 
 
Table 1: Enzymes and antibodies used 
Enzyme Source 
Benzonase Novagen 
DNase I Roche 
PreScission® Protease GE Healthcare / HZI 
Trypsin Sigma 
α-Chymotrypsin Sigma 
Endoproteinase GluC Sigma 
T4 DNA Ligase New England Biolabs 
Platinum Pfx DNA Polymerase Invitrogen 
Pfu turbo polymerase Stratagene 
Vent DNA polymerase New England Biolabs 
Restriction endonucleases: 
BamHI, EcoRI, NotI 
New England Biolabs 
Antibody  
Anti-GST-HRP Conjugate GE Healthcare 
α-YscU211-354  (Rabbit) G.C. Cornelis, (University 
Basel, Switzerland) 
α-LcrV (Rabbit) G.C. Cornelis, (University 
Basel, Switzerland) 
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3.1.2 Molecular weight standards and kits 
Table 2: Enzymes and antibodies used 
Molecular weight standard Source 
Smart Ladder (DNA) Eurogentec 
Low molecular weight (Protein) Fermentas 
Precision Plus Protein All Blue 
Standards (Protein) 
BIO-RAD 
Kits  
QIAprep® Spin Miniprep Kit Qiagen 
QIAquick® PCR Purification Kit Qiagen 
QuikChange® Site-Directed  
Mutagenesis Kit 
Stratagene 
 
3.1.3 Crystallization screens 
The following commercial screens (QIAGEN) were used to screen for initial 
crystallization conditions: 
The AmSO4 The PACT 
The Anions ProComplex 
The Cations JCSG+ 
The Classics JCSG Core I 
The Cryo JCSG Core II 
The MbClass JCSG Core III 
The MPD JCSG Core IV 
The PEGs SM I  
The pHClear SM II 
 
3.1.4 Oligonucleotides 
Table 3: Sequences of primers used in PCR and site directed mutagenesis. Restriction- and 
mutation-sites are bold and underlined in the sequence. For mutagenesis only forward primers are 
listed 
Designation Sequence (5’→3’) Restriction 
site 
Primers used in polymerase chain reactions  
 
GST-6His-YscU211-
354-fwd 
aaggagggatcccatcaccatcaccatcacattaaggaacttaaaatgagcaagg BamHI 
GST-6His-YscU211-
354-rev 
aaggaggcggccgcttataacatttcggaatgctgtttc NotI 
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GST-6His-YscV356-
704-fwd 
aaggaggaattccatcaccatcaccatcacgcaaacaagggccgactaggg EcoRI 
GST-6His-YscV356-
704-rev 
aaggaggcggccgctcataagcaaaactcgtccaagtg NotI 
3704 gatcgaattcttataacatttcggaatg EcoRI 
3724 gatcccatggccagcggagaaaagacagag NcoI 
Primers used for mutagenesis in E.coli Mutation 
YscUC- N263D-fwd catcagtggtggtagcgatccgacccatattgctattg N263D 
YscUC- N263Q-fwd catcagtggtggtagctcagccgacccatattgctattg N263Q 
YscUC- P264A-fwd gtggtggtagctaatgcgacccatattgctattgg P264A 
YscUC- P264G-fwd ctcatcagtggtggtagctaatgggacccatattgctattgg P264G 
YscUC- H266A-fwd gtggtagctaatccgaccgcgattgctattggtattctttataagc H266A 
YscUC- R296A-fwd cccaagttcagactgtggccaaaatagcagaagaagaaggg R296A 
YscUC- R314A-fwd caacgtatcccattagccgctgctctttattgggatgcgctcg R314A 
Primers used for mutagenesis in Yersinia 
4842 atcccattagccgctgctctttattgg R314A 
4956 gtggtggtagctcagccgacccatattg N263Q 
4958 gctaatccgaccgctattgctattgg H266A 
5031 gctcatcagtggtggtagctaatgggacccatattgctattggtattctttataagc P264G 
5033 cgatgcccaagttcagactgtggccaaaatagcagaagaagaagg R296A 
 
3.1.5 Plasmids 
Table 4: Plasmids used. 
Plasmids Current strain 
designation 
Genotype and derivation  References  
pYV plasmids    
pYV40 WT pYV plasmid from Y. enterocolitica E40 Sory et al., 1995 
pYVe22703 pYVe22703 pYV plasmid from  Y. enterocolitica 
W227 serotype O:9 
Cornelis et al., 1987 
pLY4001 ∆yscU pYV40 ∆yscU; deletion of yscU codons 
1-354  
Sorg et al., 2007 
Expression plasmids for E. coli  
pGEX-6-P1   GE Healthcare 
pGEX-6-
P1_YscUC 
YscUC 435 bp BamHI/AvaI fragment of yscU 
(211-354) in pGEX-6P-1 
G.C. Cornelis, Basel, 
CH 
pGEX-6-
P1_YscUC His6 
His6-YscUC 453 bp BamHI/NotI fragment of yscU 
(His6 + 211-354) in pGEX-6P-1 
this work 
pGEX-6-
P1_YscUC 
N263A 
YscUC N263A Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
N263D 
YscUC N263D Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
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pGEX-6-
P1_YscUC 
N263Q 
YscUC N263Q Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC P264A 
YscUC P264A Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
P264G 
YscUC P264G Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
H266A 
YscUC H266A Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
R314A 
YscUC R314A Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
R296A 
YscUC R296A Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscUC 
H266A/R314A 
YscUC 
H266A/R314A 
Site-directed mutagenesis of pGEX-
6P-1_YscUC 
this work 
pGEX-6-
P1_YscVC  
YscVC 1152 bp EcoRI/AvaI fragment of yscV 
(322-704) in pGEX-6P-1 
G.C. Cornelis, Basel, 
CH 
pGEX-6-
P1_YscVC 356 
His6 
His6-YscVC 356 1071 bp EcoRI/NotI fragment of yscU 
(His6 + 322-704) in pGEX-6P-1 
this work 
pGEX-6-
P1_YscVC 356 
YscVC 356 1053 bp EcoRI/AvaI fragment of yscV 
(356-704) in pGEX-6P-1 
G.C. Cornelis, Basel, 
CH 
pGEX-6-
P1_YscVC C595S 
YscVC C595S Site-directed mutagenesis of pGEX-
6P-1_YscVC 
this work 
pGEX-6-
P1_YscVC C703S 
YscVC C703S Site-directed mutagenesis of pGEX-
6P-1_YscVC 
this work 
pGEX-6-
P1_YscVC 
C595S/C703S 
YscVC 
C595S/C703S 
Site-directed mutagenesis of pGEX-
6P-1_YscVC 
this work 
Expression plasmids for Yersinia  
pBADMycHisA   Invitrogen 
pLY7 yscU+++ pBAD:: yscU; yscU was amplified from 
pYVe22703 using oligos 3704 and 3724 
and cloned into the NcoI / EcoRI sites of 
pBADmycHisA 
Sorg et al., 2007 
pSTW7 yscUN263A+++ pBAD:: yscUN263A; mutation N263A was 
introduced into pLY7 by site-directed 
mutagenesis using oligos 3725 and 3726 
Sorg et al., 2007 
pISO153 yscUR314A+++ pBAD:: yscUR314A; mutation R314A was 
introduced into pLY7 by site-directed 
mutagenesis using oligos 4842 and 4843 
Wiesand et al., 2009 
pISO166 yscUN263D+++ pBAD:: yscUN263D; mutation N263D was 
introduced into pLY7 by overlapping PCR 
using oligos 3724/4955 and 4954/3704 
Sorg et al., 2007 
pISO167 yscUN263Q+++ pBAD:: yscUN263Q; mutation N263Q was 
introduced  into pLY7 by overlapping PCR 
Wiesand et al., 2009 
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using oligos 3724/4957 and 4956/3704 
pISO168 yscUH266A+++ pBAD:: yscUH266A; mutation H266A was 
introduced  into pLY7 by overlapping PCR 
using oligos 3724/4959 and 4958/3704 
Wiesand et al., 2009 
pISO169 yscUH266A/R314
A
+++
 
pBAD:: yscUH266A/R314A; mutation H266A 
was introduced  into pISO153 by 
overlapping PCR using oligos 3724/4959 
and 4958/3704 
Wiesand et al., 2009 
pISOA174 yscUP264G+++ pBAD:: yscUP264G; mutation P264G was 
introduced into pLY7 by site-directed 
mutagenesis using oligos 5031 and 5032 
Wiesand et al., 2009 
pISOA175 yscUR296A+++ pBAD:: yscUR296A; mutation R296A was 
introduced into pLY7 by site-directed 
mutagenesis using oligos 5033 and 5034 
Wiesand et al., 2009 
 
3.1.6 Bacterial strains 
Table 5: Bacterial strains used. 
E.coli strain Genotype Source 
Top10 F–, mcr A ∆(mrr-hsdRMS-mcrBC) Φ80 lacZ ∆ M15 ∆lacX74 
recA1 araD139 ∆(ara-leu)7697 gal U gal K rpsL 
endA1nupG 
Invitrogen 
XL1-Blue  
supercompetent cells 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´proAB lacIqZ∆M15 Tn10 (Tetr)]. 
Stratagene 
Tuner (DE3) F– lacY ompT gal dcm lon hsdSB(rB– mB–) (DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Novagen 
 
3.1.7 Media and Buffer  
Media and special buffers were subjected to autoclave sterilization (121 °C, 2 bar, 20 
min, Top7000PST, Sauter, Sulgen, Switzerland). Ampicillin (100 mg/mL) was added 
after media cooling below 50 °C.  
 
Table 6: Media and buffers used. 
Designation  Composition 
Media 
 
Luria Bertani (LB) 10 g/L tryptone, 5 g/L, NaCl, 5 g/L yeast extract 
Terrific Broth (TB) 900 mL basic medium (12 g tryptone, 24 g yeast extract, 4 mL 
glycerol), completed with 100 mL buffer solution (0.17 M KH2PO4, 
0.72 M K2HPO4) 
SOC-Medium 20 g/L tryptone, 5 g/L yeast extract, 0.5 g/L NaCl, 2.5 mM KCl, 
10 mM MgCl2, 20 mM glucose 
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Minimal Medium (MM) Basic medium (1 g/L NH4Cl, 3 g/L KH2PO4, 6 g/L Na2HPO4*7H2O, 
autoclaved); completed with 100 mL supplementary solution (20% 
(v/v) glucose, 0.3% (w/v) MgSO4, 10 mg Fe2(SO4)3, 10 mg thiamine 
and 50 mg L-SeMet or 1 g 15NH4Cl; adjust solution to pH 7.4 
Buffers/Solutions 
AF4 running buffer PBS, 0.003 M sodium azide 
Blocking buffer 5% (w/v) skim milk in PBST 
Cleavage buffer I 25 mM CHES (pH 7.0, 9.0 and 10.0), 100 mM NaCl 
Cleavage buffer II 25 mM CHES (pH 7.0, 10.0 and 11.0), 100 mM NaCl 
DNA loading buffer (10x) 10 mM Tris/HCl, pH 7.5, 0.05% (w/v) bromphenol blue, 1 mM EDTA, 
50% glycerol 
DTNB buffer 50 mM Tris/HCl pH 8.0, 10 mM DTNB 
Epitope MBS buffer 80% (v/v) T-TBS (pH 8.0), 20% (v/v) blocking buffer (Sigma B6429), 
5% (w/v) sucrose  
Epitope SM-A buffer 8 M Urea, 1% (w/v) SDS, 0.5% (v/v) β-mercapto ehtanol, adjusted to 
pH 7.0 with acetic aicid 
Epitope SM-B buffer 10% (v/v) acetic acid, 50% (v/v) ethanol, 40% (v/v) H2O 
Epitope TBS buffer 50 mM Tris/HCl, pH 7.0, 3 mM KCl, 137 mM NaCl, 
Epitope T-TBS buffer TBS, 0.05% (v/v) Tween-20 
GPC buffer 20 mM HEPES pH 7.0, 150 mM NaCl 
GST elution buffer 50 mM Tris/HCl pH 8.0, 150 mM NaCl, 10 mM reduced glutathione 
Ion exchange buffer A 20 mM HEPES pH 7.0, 100 mM NaCl  
Ion exchange buffer B 20 mM HEPES pH 7.0, 1 M NaCl 
Limited proteolysis buffer 50 mM Tris/HCl, pH 8.0, 100 mM NaCl, 
Lysis buffer 1xPBS, 1 tablet protease inhibitor cocktail (Complete mini, Roche), 
125 U DNase (Benzonase, Merck) or spatula point DNase 
NMR buffer 50 mM NaCl, 3 mM KCl, 12 mM Na2HPO4, 2 mM KH2PO4, pH 6.8 
PAGE dehydrating solution 50% (v/v) methanol, 3% (v/v) glycerol 
PAGE destaining solution 40% (v/v) ethanol, 10% (v/v) acetic acid 
PBS buffer 137 mM NaCl, 3 mM KCl, 12 mM Na2HPO4, 2 mM K2HPO4, pH 7.4 
PBST buffer PBS buffer, 0.1% (v/v) Tween-20 
Ponceau Red staining solution 0.2% (w/v) Ponceau S, 2% (v/v) acetic acid 
PreScission protease 
cleavage buffer 
50 mM Tris/HCl, pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT  
SDS-PAGE Lower buffer (4x) 1.5 M Tris/HCl, pH 8.8 
SDS-PAGE running buffer 25 mM Tris/HCl, 192 mM glycine, 0.1% (w/v) SDS  
SDS-PAGE sample buffer (2x) 1 mL 1 M Tris/HCl pH 6.8, 2.4 mM glycerol, 0.8 g SDS, 2 mg 
Coomassie blue G-250, 0.31 g DTT, add H2O to 10 mL 
SDS-PAGE separating gel 10 mL Polyacrylamide solution, 5 mL 4 x Lower buffer, 0.2 mL SDS 
(10%), 4.7 mL H2O, 20 µL TEMED, 50 µL APS (25%) 
SDS-PAGE stacking gel 1.5 mL Polyacrylamide solution, 2.5 mL 4 x Upper buffer, 5.9 mL 
H2O, 15 µL TEMED, 25 µL APS (25%) 
SDS-PAGE staining solution 30% (v/v) ethanol, 10% (v/v) acetic acid, 0.25% (w/v) Coomassie R-
250  
SDS-PAGE Upper buffer (4x) 0.5 M Tris/HCl pH 6.8, 0.4% (w/v) SDS  
TAE buffer 40 mM Tris/HCl pH 8.2, 20 mM sodium acetat, 1 mM EDTA 
Transfer buffer 20 mM Tris pH 8.0, 192 mM glycine, 15% methanol 
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3.2 Molecular cloning 
Bacterial strains, plasmids and genetic constructions are given in Table 4 and Table 5 
E. coli Top10 or XL1-Blue strains were used for plasmid purification and cloning. 
Bacteria were grown routinely on Luria-Bertani (LB) agar plates and in liquid LB-
medium. Ampicillin was used at concentrations of 200 µg/mL. 
Plasmids were generated using either the Pfu turbo polymerase (Stratagene) or Vent 
DNA polymerase (New England, Biolabs). Oligonucleotides for genetic constructs are 
given in Table 3. All constructs were confirmed by sequencing using a 3100-Avant 
genetic analyser (ABI Prism) or by the companies GATC (Konstanz, Germany) or 
MWG (Ebersberg, Germany). 
 
3.3 Protein production and purification 
3.3.1 Expression and purification of YscUC 
Standard expression of YscUC 
Testing different media, temperatures and E. coli cells, the following optimal 
expression conditions were found. The YscUC-pGEX-6P-1 vector was transformed 
into E. coli Tuner (DE3) cells and cultivated on LBA agar plates overnight. For further 
preparations and long term storage a glycerol culture was produced. A single colony 
was used to inoculate a pre-culture of 20 mL LBA medium. 10 mL pre-culture, which 
had been grown at 37 °C and 180 rpm to an OD 600 of 0.6, was transferred into 1 L 
main-culture (TBA medium). After the main culture reached an OD600 of 0.6 (37 °C, 
110 rpm), expression of yscUC was induced by adding 0.2 mM isopropyl 
thiogalactopyranoside. Shifting the temperature to 20 °C prevented the formation of 
inclusion bodies. After incubation for further 16 h, cells were harvested by 
centrifugation (6,080 xg, 15 min, 4 °C), resuspende d in ice cold lysis buffer and 
stored at -20 °C for future preparations.  
 
Production of labelled protein of YscUC 
L-Selenomethionine (SeMet)-labelled and 15N-labelled YscUC N263A, as well as 15N-
labelled YscUC wild type variants were produced by using a protocol based mainly on 
(Guerrero et al., 2001). All variants were freshly transformed and plated on LBA agar 
plates. A single colony was used to inoculate an overnight culture of LBA medium. 
Cells were centrifuged (2,700 xg, 4 °C, 10 min), wa shed carefully in ice cold sterile 
ddH2O and again centrifuged (2,700 xg, 4 °C, 10 min). T he bacterial pellet was 
diluted in the desired minimal medium to an OD600 1.0 and incubated for 20 min at 
37 °C. Expression was induced by adding 0.2 mM isop ropyl thiogalactopyranoside 
and further incubation at 20 °C for 20 h. Finally c ells were centrifuged (6,080 xg, 
4 °C, 15 min) and resuspended in lysis buffer. 
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Purification of YscUC 
Efficient cell lysis was performed by running lysis suspension twice through a 
homogenizer (20,000 kPsi, 4 °C). Cell debris and in soluble components were 
separated by centrifugation (37,060 xg, 45 min, 4 °C). Supernatant was incubated 
with equilibrated (PBS buffer) glutathione sepharose for 4 h at 4 °C. Unbound protein 
was washed three times (50 mL) from the GS column with protease buffer.  
To obtain GST-labelled YscUC, sepharose was incubated five times (50 mL) with GST 
elution buffer. GST-YscUC wash and elution fractions were analysed by SDS-PAGE 
and concentrated (10 - 15 mg/mL). 
The GST fusion tag was cleaved off by adding 75 µL PreScission protease (500 U) in 
10 mL protease buffer and incubation (4 °C) overnig ht. Only YscUC is eluted from the 
column, as the protease is also GST-tagged. Finally the GST-sepharose was washed 
with 10 mM reduced glutathione in 10 mL protease buffer to control cleavage 
efficiency. Purity and cleavage efficiency were analyzed using a SDS-gel. YscUC 
containing fractions were pooled and dialysed against IEC buffer A (SnakeSkin 
membrane, MWCO 3,500, Thermo Scientific). 
As YscUC is positively charged at pH 7.0 (theoretical pI 8.1, calculated with Vector 
NTI InforMax), the second purification step was performed using cation exchange 
chromatography (MonoS 10/100 column). Runs were programmed containing two 
linear step gradients: 1st 0-30 % IEC buffer B in 3 column volumes and 2nd 30-100% 
IEC buffer B in 1 column volume. YscUC was eluted as a single peak at ~19 % IEC 
buffer B (~ 20 mS/cm). YscUC containing fractions were analyzed by SDS-PAGE, 
pooled and concentrated to 5 – 15 mg/mL (Vivaspin concentrator, MWCO 10,000). 
As final purification step gel permeation chromatography was performed using a 
Superdex 16/60 prep grade column (GE Healthcare).  
 
3.3.2 Expression and purification of YscVC 
Expression of YscVC 
After transformation of YscVC-pGEX-6P-1 into E.coli Tuner (DE3) cells, over-
expression was performed as described for YscUC in Chapter 3.3.1. For long term 
storage and further preparations glycerol cultures were produced. 
 
Purification 
Resuspended cells were lysed by running cell suspension twice through a 
homogenizer (20,000 kPsi, 4 °C). Cell debris and in soluble components were 
separated by centrifugation (37,060 xg, 45 min, 4 °C).The supernatant was incubated 
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with 10 mL glutathione sepharose (equilibrated in PBS buffer) for 4 h at 4 °C. 
Unbound material was washed three times (50 mL) from the GS column with 
PreScission protease cleavage buffer sepharose was further incubated four times (3 
x 10 mL, 1 x 20 mL) with GST elution buffer and analyzed by SDS-PAGE. GST-
YscVC fractions were pooled and a 75 µL sample of PreScission Protease (GE 
Healthcare, 500 U) was added to cleave the GST fusion protein. After 45-60 min of 
protein cleavage, small amount of protein precipitation was observed and cleavage 
was immediately terminated by adding one tablet of Complete Mini (Roche). In a 
second step the protein was further purified using an ion-exchange column. As YscVC 
is negatively charged at pH 7.0 (theoretical pI 5.2, calculated with Vector NTI 
InfroMax), protein solution was applied to a MonoQ 10/100 column (GE Healthcare). 
The column was equilibrated with ion exchange buffer A and YscVC was eluted in a 
single peak within a linear gradient (0.1 M -1 M NaCl) at 35 % ion exchange buffer B. 
YscVC-containing fractions were identified by SDS-PAGE and concentrated to 10 – 
15 mg/mL. 
 
3.4 Protein analytical methods 
3.4.1 Discontinuous SDS-polyacrylamide gel electrophoresis 
A discontinuous SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried 
out to analyse the purity, amount and molecular weight of the proteins (Laemmli, 
1970). The SDS-gels used in this work were performed with a 5 % (w/v) acrylamide 
stacking gel and a 15 % (w/v) acrylamide separating gel (Chapter 3.1.7). Protein 
samples (2-15 µL) were incorporated with SDS-PAGE sample buffer (10-20 µL) and 
briefly (60 sec) boiled at 95 °C. 12 µL of these sa mples and 5 µL marker were loaded 
on a SDS-gel. The SDS-PAGE was run constantly at 40 mA and terminated upon 
reaching the dye front at the end of the gel. After electrophoresis, gels were stained 
in a Coomassie Brilliant Blue R-250 solution by boiling and shaking. To remove 
excess stain, gels were destained. Finally gels were dried between cellophane 
papers for storage. 
 
3.4.2 Limited proteolysis 
Limited proteolysis was used to identify globular and stable protein domains. 
Therefore purified protein was diluted in limited proteolysis buffer to a final 
concentration of 0.3 – 1 mg/mL in a 100 µL reaction volume. typsin, α-chymotrypsin 
and endoproteinase GluC were added in a protein/protease ratio of 1:200 (w/w) in 
each trial reaction. After distinct time points 10 µL aliquots were taken and proteolysis 
was stopped by mixing with 10 µL SDS-PAGE sample buffer (0.1 mM AEBSF (4-(2-
aminoethyl)- benzenesulfonyl fluoride)) and heating for 60 sec at 95 °C. Until further 
analysis by SDS-PAGE all samples were frozen at -20 °C. 
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3.4.3 pH-dependent cleavage of YscUC variants 
The different YscUC variants were expressed and purified as described above. 
Variant P264A was dialysed against 25 mM Ches-buffer, 100 mM NaCl for 3h at room 
temperature. P624G, H266A/R314A and N263D were dialysed against 25 mM CAPS-
buffer, 100 mM NaCl for 4h at room temperature. Afterwards, the variant P264G was 
stored for 48 h and H266A/R314A and N263D were stored for 24 h at 4 °C. Cleaved 
proteins were submitted to SDS-PAGE (15%) and stained with Coomassie brilliant 
blue. 
 
3.4.4 Western blot and immunodetection 
Protein samples from SDS-gels were transferred via electrophoresis on a polyvinyl 
difluoride (PVDF) membrane (Towbin et al., 1979) and used for immunodetection or 
N-terminal sequencing. The non-stained SDS-gel was incubated for 15 min in 
transfer buffer and placed onto the activated PVDF membrane (incubation 60 sec in 
methanol and 5 min in transfer buffer). Membrane and gel were placed in between 
two transfer-buffer-soaked Whatmann tissues and fixed in the semi-dry blot chamber 
(TransBlot semi-dry transfer cell, Bio-Rad). Transfer was carried out at constant 15 V 
for 45 min and successfully transfer was evaluated by Ponceau Red staining. 
For immunodetection the blotted PVDF membrane was incubated for 1 h in 50 mL 
blocking buffer and washed three times with PBST buffer (10 mL, 5 min). Primary 
antibodies were diluted (α-GST-HRP conjugate 1:5000, α-YscUC 1:1000) in PBST 
buffer and incubated with PVDF membrane for 1 h and again washed three times 
with PBST buffer. A secondary α-rabbit-HRP-antibody (1:5000) for α-YscUC was 
necessary for detection and therefore the membrane was incubated and washed a 
second time. To detect target proteins the Enhanced Chemiluminescence kit (ECL) 
(LumiLight, Roche) was used. 
 
3.4.5 Qualitative determination of accessible Sulfhydryl groups 
The accessibility of protein sulfhydryl groups was determined qualitatively using 
Ellman`s regant (5,5’-Dithio-bis(2-nitrobenzoic acid, DTNB). 2 µL DTNB-solution (10 
mM in 0.1 M Tris pH 8.0) were incubated with 1 µL protein solution (1 mg/mL) for 
5min. The release of TNB (2-nitro-5-mercaptobenzoic acid) during the reaction was 
measured photometrically at 412 nm. 
 
3.4.6 Mass spectroscopy 
For protein identification and conformation of correct protein labelling samples were 
analysed using MALDI-TOF-MS (Matrix Assisted Laser Desorption Ionisation – Time 
Of Flight) or ESI-MS (Electrospray Ionisation). The experiments were carried out by 
Dr. Manfred Nimtz and Undine Felgenträger (HZI, Braunschweig). 
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3.4.7 N-terminal sequencing 
For evaluating and identification of proteins the N-termini were sequenced by 
automated Edman degradation (Edman & Begg, 1967). The protein samples were 
separated by SDS-PAGE and blotted onto PVDF membranes as described in 
Chapters 3.4.1 and 3.4.4. Blotted proteins were stained with Ponceau red and the 
corresponding bands were cut out for sequencing. N-terminal sequencing was 
performed by Rita Getzlaff (HZI, Braunschweig) using the 494A HT Protein 
Sequenzer (Applied Biosystems). 
 
3.4.8 ThermoFluor assay 
The ThermoFluor assay is a rapid screening method to identify optimal protein 
stabilizing conditions by varying pH, small molecules and buffer. A fluorescent dye, 
which has an affinity for the hydrophobic core of proteins, is added to the protein 
solution. In the following a differential fluorimetry scan is performed creating a 
temperature gradient. Once the melting temperature of the protein is reached, 
fluorescence is increased due to unfolding of protein. A simple calculation affords the 
exact melting temperature. The highest given melting temperature corresponds to the 
best stabilization conditions (Niesen et al., 2007). 
Differential scanning fluorimetry was performed on a CFX96 Real-Time Thermal 
Cycler C1000 (Bio Rad) instrument. In order to choose appropriate scanning 
conditions an initial scan was carried out varying protein and dye concentrations. For 
this 40 µL protein buffer were mixed with 5 µL protein (0.1, 1 and 2 mg/mL) and 
Sypro Orange 5000x (10-, 50- and 100x) in a 96-well plate (Multiplate 96-Well 
Unskirted PCR plate, Bio Rad). The plate was sealed using a non-fluorescence 
absorbing seal (Microseal ’B’. Adhesive Seal, Bio Rad).The best protein/dye 
combination (increase of fluorescence > 800 U) was chosen for the main screen, in 
which the different buffer conditions were tested. The conditions were adapted from a 
protocol of Vedadi group (Niesen et al., 2007). Runs were performed using a linear 
gradient (10 - 90°C) measuring fluorescence intensi ty every 0.5 °C. The data were 
analyzed using the CFX software (Version 1.5, Bio Rad). 
 
3.4.9 Epitope scan 
An epitope scan is a method for investigating interaction sites of proteins and also for 
determining the influence of amino acids on the binding affinity (Dooley & Houghten, 
1993). For this purpose one binding partner is split into peptide fragments. Theses 
peptides were synthesized and spotted on a cellulose membrane. The potential 
binding partner is incubated with the membrane and binding is analysed by 
immunodetection (Figure 8). 
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The choice of the correct peptides depends on previous information about the two 
potential binding partners. If there is no information on binding behaviour, one protein 
is fragmented into overlapping peptides and incubated with its potential partner. The 
standard peptide length is a 15mer, which will be shifted by three amino acids along 
the primary protein sequence. Such a rough epitope scan is called a 15/3 scan and is 
used for localisation of binding sites (Dooley & Houghten, 1993). For exact 
localisation a 15/1 run is used afterwards. Once the binding areas are detected, the 
role of individual amino acids can be investigated. In these further scans each amino 
acid in the peptide is exchanged sequentially against either alanine (alanine scan) or 
every other amino acid (amino acid scan) (Frank, 2002).  
 
Figure 8: Functionality of the epitope scan. A GST-tagged target protein is captured by an 
anchored peptide and detected via an HRP-linked GST-antibody. 
 
All peptides were synthesized and spotted onto cellulose membranes by Dr. Ronald 
Frank and Dr. Werner Tegge (HZI, Braunschweig). The prepared membrane was 
soaked in ethanol, washed three times with TBS buffer (10 mL, 10 min) and 
incubated in 10 mL MBS buffer at room temperature overnight. After washing (10 mL 
T-TBS, 10 min) once, the membrane was incubated with a 1 - 4 mg/mL protein 
solution diluted 1:200 in 10 mL MBS buffer for 4 h. Again the membrane was washed 
three times (10 mL T-TBS, 10 min) and incubated with a GST-HRP conjugate diluted 
1:5000 in 10 mL MBS buffer for 2 h. After a further washing round (three times 10 mL 
T-TBS, 10 min), the membrane was stained using the Enhanced Chemiluminescence 
kit (ECL) (LumiLight, Roche). 
For reuse of the membranes proteins and antibodies were removed in the following 
way: The membrane was washed in 20 mL water (three times for 10 min), 20 mL SM-
A (three times for 10 min), 20 mL SM-B (three times for 10 min) and finally in 20 mL 
EtOH. Membranes were air-dried and stored in a shrink-wrap film at -20 °C for future 
use. 
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To test the membranes for unspecific interactions all membranes were initially 
incubated with GST and antibody. Control and experiment were repeated two times, 
respectively. 
 
3.4.10 Dynamic light scattering 
All purified protein samples were analyzed by dynamic light scattering (DLS) to 
assess their polydispersity. The method was also used to confirm the estimated 
molecular weight assuming a globular shape. Since huge particles disturb 
measurements, protein solutions (0.5 – 1 mg/mL) were centrifuged (20 min, 
14,000 xg) and 15 µL sample volumes were transferred in a dust-free DLS-cuvette. 
The experiments were carried out at room temperature on a DynaPro Titan 
Temperature Controlled MicroSampler instrument (Wyatt Technologies). The laser 
power was set to yield at least 1,000,000 counts/sec. To analyze data, DYNAMICS 
V6 (Version 6.10.1.2) software was used. Protein solutions with suitable 
polydispersity (< 20%) were used for crystallization trials. 
 
3.4.11 Asymmetric flow field flow fractionation 
Asymmetric flow field flow fractionation (AF4) is a one-phase chromatography 
technique (Figure 9), which enables a sharp and gentle separation of protein 
solutions in flow fields (Giddings, 1993). In combination with static light scattering and 
refraction measurement the received fractions can be analysed towards 
oligomerisation status and concentration. The separation process needs three steps. 
During injection (step 1) the sample is collected under the injection port due to a 
balanced flow. At the same time the sample is focussed (step 2) in a thin band 
towards the membrane. Diffusion associated with Brownian motion, in turn, creates a 
counteracting motion. Smaller proteins, which have a higher diffusion rate, reach 
upper levels and thus a molecular weight gradient is built. To separate and elute the 
proteins a second perpendicular flow is injected (step 3). Because of the laminar flow, 
the flow field is parabolic and thus smaller molecules reach a higher velocity. In 
contrast to gel permeation chromatography the smaller proteins in AF4 will be eluted 
first (Podzimek et al., 2008). 
All experiments were carried out on an Eclipse 3 AF4 system (Wyatt Technology), 
which was combined with a Dawn Heleos II Lightscattering K5 MALS device (multiple 
angle light scattering, Wyatt Technology) and Optilab rEX refractometer (Wyatt 
Technology). As the technique is sensitive to dust the running buffer was filtered (0.2 
µm) twice. Sodium azide (0.003 M) was added to prevent fungal and bacterial 
growth. Runs were performed in a small channel (size S) equipped with a 0.35 µm 
spacer and 10 kDa cellulose membrane. The detector flow and the focus flow were 
set to 1.0 ml/min and 1.5 mL/min, respectively. Samples were injected with a flow 
rate of 0.2 ml/min. Channel separation quality was checked by using BSA before and 
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after each run. Data were processed with the ASTRA software (Version 5.3.2.20, 
Wyatt Technology Corporation). 
 
 
Figure 9: Principle of the AF4 technique. At first the sample is injected into a channel, where it 
focused and equilibrated in a thin layer. Due to a further perpendicular and parabolic flow, particles 
were separated along the channel. 
 
3.5 In vivo analyses 
Within the scope of the injectisome collaboration between the HZI and the group of 
Guy R. Cornelis (University of Basel, Switzerland) all in vivo experiments with 
Yersinia enterocolitica were carried out by Dr. Isabel Sorg, Marlise Amstutz and 
Stefanie Wagner. The aim was to characterize different YscU variants with respect to 
their secretion behaviour and their needle length.  
 
3.5.1 LcrV secretion and immunoblotting 
Induction of the yop regulon was performed as described by Cornelis et al., 1987. 
Expression of the different genes cloned downstream of the pBAD promoter was 
induced routinely by adding 0.2% L-arabinose to the culture before shift from 28 °C t o 
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37 °C, and again 2 h later. Glycerol (4 mg/ml) was added as a carbon source when 
expressing genes from the pBAD promoter. Total cell and supernatant fractions were 
separated by centrifugation at 20,800g for 10 min at 4 °C. The cell pellet was taken 
as the total cell fraction. Proteins in the supernatant were precipitated with 10% (w/v) 
trichloroacetic acid (final concentration) for 1 h at 4 °C.  
Supernatant (SN) and total cell (TC) fractions were separated by 12% SDS-PAGE. In 
each case, proteins secreted (SN) or produced (TC) by 2.5 x 107 bacteria were 
loaded in each lane. Immunoblotting was performed using rabbit polyclonal 
antibodies against LcrV (MIPA220; 1:2000). Detection was performed with the 
respective secondary antibodies conjugated to horseradish peroxidase (1:5000; 
Dako), before development with supersignal chemiluminescent substrate (Pierce).  
 
3.5.2 Electron microscopy 
T3SS needles were visualized by transmission electron microscopy as described 
(Agrain et al., 2005; Hoiczyk & Blobel, 2001). After induction of the yop regulon for 4 
h at 37 °C bacteria were harvested by centrifugatio n at 2000 xg and resuspended 
gently in 20 mM Tris-HCl, pH 7.5. Droplets were applied for 1 min to freshly glow-
discharged, formvar-carbon coated grids, and negatively stained with 2 % (w/v) 
uranyl acetate. Bacteria were visualized in a Philips CM100 transmission electron 
microscope at a nominal magnification of 20,000 xg and an acceleration voltage of 
80 kV. Needle sizes were measured with the Soft imaging system software 
(Hamburg, Germany). 
 
3.6 Protein crystallization 
Concentrated and purified proteins were filtered (0.2 µm) or centrifuged (20 min, 
18,800 xg, 4 °C) before crystallizing. All proteins  were crystallized by hanging- and 
sitting-drop vapour diffusion methods at constant temperatures (20 or 4 °C).  
Initial screening 
Initial screening experiments for crystallization conditions were performed with 
commercially available screens (Quiagen, see Chapter 3.1.3). For this purpose the 
sitting-drop method in 96-well plates (Greiner) was used for crystallization. 300 nL 
purified protein and an equal amount of reservoir were mixed in a droplet using a 
pipetting roboter (Mosquito robot, TTP LabTech). Plates were sealed using a 
MancoTM Crystal Clear tape (Jena Bioscience) and incubated at 4 or 20 °C. 
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Optimization 
Initial hit conditions were optimized manually in 24-well hanging drop and sitting drop 
formats. Drop volumes were enlarged to 2-5 µL and physico-chemical parameters 
such as precipitant, protein concentration, pH, ionic strength and temperature were 
varied producing crystals suitable for X-ray diffraction experiments.  
Macro- and micro-seeding (Bergfors, 2003; Luft & DeTitta, 1997), Additive Screen 
(Hampton Research), varying crystallization temperatures, truncation of flexible 
regions (Dale et al., 2003) and cysteine replacements were used for further crystal 
improvement and to get larger crystals. 
Cryo-crystalography 
As X-ray radiation causes radiation damage in protein crystals (Garman & Owen, 
2006), data sets were collected at cryogenic temperatures (~100 K) to minimize 
these effects. Upon freezing, however, water can also crystallize and water ice 
imposes a mechanical stress on the protein crystal resulting in loss of diffraction or 
ice-rings on the diffraction pattern. Therefore a cryo-protection for protein crystals is 
needed. This is achieved by adding cryo-protectants such as PEG 400, glucose, 
ethylene glycol or glycerol. In this work an aliquot of the original reservoir solution 
was mixed with glycerol to yield a final concentration of 15-20% (v/v), depending on 
the actual crystallization conditions. Crystals were harvested with a nylon loop, 
quickly transferred into the cryo-protecting solution and then flash frozen in liquid 
nitrogen. 
 
3.7 X-ray structure analysis 
Single crystal X-ray crystallography is a powerful method to determine the three 
dimensional structures of proteins at atomic resolution. Protein crystals are irradiated 
with a monochromatic X-ray beam. Upon interaction of X-ray radiation and matter 
(protein crystal), electrons interact with the changing electromagnetic field and in turn 
begin to oscillate. As oscillating dipoles, they emit coherent radiation with the same 
wavelength as the incident radiation. This effect is called elastic or Thomson 
scattering. Under certain crystal orientations the emitted waves interfere 
constructively (Bragg’s law), yielding detectable reflection spots. The symmetry of the 
resulting reflection pattern directly corresponds to the crystal lattice, while the 
intensity distribution depends on the electron density distribution within the unit cell. 
To calculate the electron density (Equation 1) the phase information is required, 
which is lost during data collection. This problem is known as the phase problem, 
which can be solved by a variety of indirect methods. 
In this study the multi-wavelength anomalous dispersion (MAD) technique was used 
to solve the phase problem. For this purpose a selenomethionine (SeMet) derivative 
protein has been produced (see Chapter 3.3.1) for structure determination 
(Hendrickson et al., 1990). 
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3.7.1 Phase determination via anomalous diffraction  
If incident X-rays are reemitted by atoms with the same phase angle, then an elastic 
scattering is observed. But when the X-ray wavelength is in the range of the 
scattered electron binding energies (heavy-atom absorption edge), a part of the 
radiation is absorbed by the heavy atoms. As a consequence of this inelastic 
interaction (Compton scattering) the reemitted intensity decreases and the phase is 
altered compared to the incident wave. This effect is designated as anomalous 
diffraction and can be accounted for the atomic scattering factor f as two 
perpendicular wavelength-depended terms (Equation 2): a real term f' (dispersive) 
and an imaginary term f'' (absorption). More importantly Friedel´s law (|Fhkl|=|F-h-k-l|) 
loses its validity. Due to the wavelength-depended contributions of the anomalous 
scatterer, the phase as well the amplitude of symmetry related reflections changes 
and thus Friedel mates differ (Equation 3). These differences of Friedel mates are 
used to obtain phase information and substructure handedness in the MAD 
experiment (Figure 10). 
 
( ) ( )λλ fifff ′′+′+= 0           Equation 2 
0f     wavelength independent atomic scattering factor      
( )λf ′ , ( )λfi ′′   real and imaginary atomic components of anomalous scattering  
 )()()(
)()()(
−
′′
−−
′+=−
+′′++′+=+
FFFF
FFFF
PH
PH
        Equation 3 
)(+F , )(−F    structure factors of Friedel mates 
PHF     structure factor of a heavy atom derivative at normal wavelength 
F ′ , F ′′    reel and imaginary components of anomalous scattering 
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Figure 10: (A) Construction of the Friedel mates at anomalous scattering. Under anomalous 
scattering, at wavelength λ2, ( )+2λPHF is no longer the mirror image of ( )−2λPHF . 
(B) Graphical vector solution using a Harker construction for MAD phasing. Once the structure 
factor 1λPHF is solved, the phase for the native data set is achieved by a simple vector difference 
1λ
PHF - 
1λ
HF  (Rhodes, 2006). 
 
In order to use anomalous differences for MAD phasing, a fluorescence energy scan 
near the absorption edge of the anomalous scatterer is performed providing the 
proteins characteristic curves for f' and f'' (Figure 11). Typically three or four different 
wavelength data sets around the absorption edge are measured to get anomalous 
signals. In particular these wavelengths are: the maximum (peak) of f'', where the 
signal for the imaginary term shows its largest value, the minimum of f' corresponding 
to the inflection point of f'' and a wavelength far away from the absorption edge (low 
and/or high energy remote). In the end one obtains for each wavelength a set of 
different anomalous signals, which can be used for phase information and 
handedness. For this method, however, all data sets need to be recorded from a 
single crystal, as the difference between Friedel mates caused by the anomalous 
scatterer is less than 5% of the entire signal. 
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Figure 11: Theoretical plot of scattering factors f'' and f' of Se as a function of the X-ray energy 
and wavelength. Plot has been generated using the edge plot web tool 
(www.bmsc.washington.edu/scatter). 
 
With the assistance of the measured anomalous differences or Bijvoet differences 
(difference between the measured amplitudes of the Friedel mates at one 
wavelength) and the dispersive differences (difference between the measured 
amplitudes of the Friedel mates at two different wavelengths) Patterson maps can be 
calculated for the anomalous scatterer. Both maps should contain the same peaks for 
solving the heavy atom substructure. From the initial positions of the anomalous 
scatterers the structure factor of FPH (+) and FPH (-) can be deduced graphically by a 
Harker construction (Figure 10). However, this method is only a graphical illustration, 
computer programs determine phase angles by the MAD observational equations 
(Hendrickson et al., 1985). In the case of MAD experiment using two different 
wavelengths (λ1 and λ2) four equations can be set up (Equation 4). Accordingly six or 
eight equations can be set up, if three or four wavelengths are used. As the structure 
factor amplitudes of FPH and FP are wavelength independent, the three unknown 
parameters FPH, FP and (αPA-αP) are over-determined by the four, six or eight 
equations. If the heavy atom substructure is already known, the protein phase angles 
can be good estimated. 
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3.7.2 Model building, refinement and validation 
Once the phase problem has been solved successfully electron density has to be 
interpreted by building a protein model. The initial model building can be done 
automatically, if data quality and resolution are sufficiently good. The final model 
building is performed manually to improve the model with regard to the chemical and 
biological properties.  
The principal aim of a protein crystal structure determination is the building of a 
reasonable model that is in good agreement with the observed data. For this purpose 
the positions of individual atoms are optimized in iterative rounds of refinement 
calculations, that improve the overall model and hence the model-derived phases. 
The fit in quality of the model to the observed data is measured by the 
crystallographic R factor Rcryst, which can be determined from the calculated model 
structure factors Fcalc and the observed structure factors Fobs (Equation 5) . Well 
defined structures generate Rcryst values of 10-25 %, whereas randomly placed atoms 
in the unit cell have a maximum value of 59 % (Wilson, 1949). In order to prevent 
over-fitting, a test set of data (usually 5-10 % of all reflections) is not used for 
refinement calculation. Using the test set of reflections, the so-called Rfree factor can 
be calculated (Brunger, 1993). If the Rfree value increases, after changing the model 
parameters, a model bias has been generated. Finally the model quality is validated 
by stereo chemical parameters (Engh & Huber, 1991), such as bond length, bond 
angles and torsion angles (Ramachandran plot) (Ramachandran & Sasisekharan, 
1968), the reliability of the R factors Rcryst/Rfree and a contact analysis of all atoms 
(Lovell et al., 2003).  
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with k the resolution-dependent scale factor 
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3.7.3 Structure determination of YscUC 
Four multiwavelength anomalous diffraction (MAD) data sets of SeMet-labelled 
YscUC N263A were collected at beamline X12 at the EMBL Outstation (Hamburg, 
Germany) and processed with the HKL2000 (Otwinowski, 1997) and MOSFLM 
(Leslie, 1992). Before collecting a whole data set, test pictures were taken to 
calculate the best data collection strategy. The solution of the selenium substructure, 
density modification and partial model building were done with the automated crystal 
structure determination platform: Auto-Rickshaw (Panjikar et al., 2005) at the EMBL-
Hamburg. Before starting the routine, the following input data was prepared. The four 
MAD data sets were processed anomalously with HKL2000 (Otwinowski, 1997). The 
obtained intensities were converted into structure factors in a MTZ file using the 
program SCALEPACK2MTZ (French & Wilson, 1978). The created MTZ files and the 
amino acid sequence of YscUC were applied to the interface and a four wave length 
MAD experiment was chosen. The program estimated from the files the unit cell 
dimensions, the number of molecules per asymmetric unit (1) and prepared an input 
file for SHELX programs. Once the program SHELX C (Pape & Schneider, 2004) had 
solved the MAD equations for the anomalous scatterer, an input file was written up to 
give a useful resolution range. The subsequent program SHELX D (Schneider & 
Sheldrick, 2002) solved the selenium substructure. Finally SHELX E (Pape & 
Schneider, 2004) solved the phasing equations. The correct substructure 
enantiomorph (P43212) was estimated by several cycles of density modifications. 
Here the contrast of the electron density map (heavy-atom) of the correct 
enantiomorph is much higher. After localization of two selenium sites a partial model 
was generated with ARP/wARP (Morris et al., 2003). Finally the model was 
completed manually using COOT (Emsley & Cowtan, 2004) and refinement was 
carried out using REFMAC5 (Murshudov et al., 1997).  
The X-ray data set of YscUC N263D was collected at ESRF beamline ID29 
(Grenoble, France), processed with MOSFLM (Leslie, 1992) and scaled with SCALA 
(Evans, 2006). Using REFMAC5 (Murshudov et al., 1997) and SeMet-labelled YscUC 
N263A as a phasing model, the structure was solved by difference Fourier and 
further refined with COOT (Emsley & Cowtan, 2004) and REFMAC5 (Murshudov et 
al., 1997).  
The validation of both structures was performed with MOLPROBITY (Davis et al., 
2007). Data collection and refinement statistics are given in Table 7. The coordinates 
have been deposited in the Protein Data Bank (PDB) under accession codes 2v5g 
and 2w0r. 
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3.8 Protein nuclear magnetic resonance spectroscopy 
In addition to X-ray crystallography protein nuclear magnetic resonance spectroscopy 
(NMR) is a further important method for elucidating the 3D structures of small 
proteins. A great advantage of protein NMR is the possibility of analyzing protein 
samples in solution. Further, once the protein structure is solved, interactions can be 
investigated more easily. A drawback is the size limitation of investigating proteins 
(~ 30 kDa) due to overlapping signals.  
Nuclei (e.g 1H, 19F or 31P), which contain a nuclear spin, exist in discrete nuclear spin 
states when they reside in an external magnetic field. NMR spectroscopy uses 
radiofrequency radiation to observe transitions between the different nuclear spin 
states. Consequently, nuclei that do not have a nuclear spin are transparent to NMR 
spectroscopy. However, this concerns the most common isotopes like 12C (98.9 %), 
14N (99.6 %) and 16O (99.8 %) nuclei. Due to the high natural abundance of these 
common isotopes, protein samples have to be labelled with isotopes possessing a 
nuclear spin. For this purpose proteins can be produced recombinantly in minimal 
media containing labelled 13C-labelled glucose or 15N-labelled ammonium chloride.  
If all nuclei absorbed energy at the same resonance frequency, NMR spectroscopy 
would not be very useful for investigations. However, as electrons of the molecule 
create a local weak magnetic field, the nuclei are shielded from the applied main 
field. Therefore the nuclei absorb, depending on their local environments, at slightly 
different frequencies, resulting in a so-called chemical shift in the NMR spectrum. 
The interpretation of a 1D spectrum is not possible for complex molecules such as 
proteins, as too many signals are overlapping. Therefore the spectrum is expanded 
to a second or third dimension by correlation of the resonance frequencies to the 
frequencies of same or hetero nuclei. The resulting peaks are mostly separated 
allowing an assignment and novel information about the chemical environment 
(Lottspeich & Engels, 2006).  
 
3.8.1 Investigation of conformational change with protein NMR 
Comparing two different protein states (e.g. before and after cleavage) can be easily 
performed by recording a HMQC (heteronuclear multiple quantum coherence) 
spectrum of both states (Gal et al., 2007). In this 2D spectrum nitrogen frequencies 
are correlated with the amide proton frequencies. Every observed peak represents a 
proton bound to its 15N-atom. This means the protein spectrum consists basically of 
peaks from HN-protons of backbone and side chain amids. A conformational change 
in the protein changes the chemical environment of the amide protons thus leading to 
different chemical shifts. From superposition of both spectra it is clear whether there 
is a conformational change or not. 
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3.8.2 The 15N, 1H HMQC experiment 
Protein NMR measurements were performed by Dr. Thorsten Lührs (HZI, 
Braunschweig). 15N-labelled YscUC variants were expressed and purified as 
described in Chapter 3.3.1. For protein NMR spectroscopy, we used a 12 mg/mL 
solution of uniformly 15N-labelled YscUC in a mixed solvent of 95% (v/v) H2O, 5% 
(v/v) 2H2O and a 10 mg/mL solution of YscUC N263A in the same solvent. The NMR 
samples contained 50 mM NaCl, 3 mM KCl, 12 mM Na2HPO4 and 2 mM KH2PO4 at 
pH 6.8. The Bruker Advance III 600 MHz NMR spectrometer used for this study was 
equipped with a 5-mm Z-axis gradient triple-resonance cryo-probehead (providing a 
better signal noise ratio). The 2D [15N,1H] correlation spectra were recorded at 
ω1 = 2100 Hz and ω2 = 8400 Hz. The maximal evolution times were t1max = 60 ms 
and t2max = 240 ms and the time domain data size was 256 × 2048. Programs PROSA 
(Guntert et al., 1992) and CARA (Keller, 2004) were used for data processing and 
spectral analysis, respectively. 
 
3.9 Bioinformatics and figure representation 
Plasmids, genes and proteins were analyzed and archived in Vector NTI version 8. 
Pair wise and multiple sequence alignments were performed using CLUSTALW 
(Thompson, 1994). Figures for protein representations were prepared using PYMOL 
(http://pymol.org). 
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3.10 Molecular orbital diagram 
A molecular orbital diagram (MO diagram) is a qualitative descriptive tool explaining 
chemical bonding in molecules. Accordingly atomic orbitals (AO) and/or molecular 
orbitals (MO) are combined using the linear combination of atomic orbitals (molecular 
orbital) method (LCAO method). The simplest case displays the σ-bound of two H-
atoms (Figure 12). Combination of both AO yield an occupied binding σ-MO (lower 
energy) and an unoccupied anti-binding σ*-MO. In a corresponding more complex 
“hybrid MO” the corresponding MOs can also be combined (Riedel & Janiak, 2002). 
 
 
Figure 12: Energy diagram of the H2 molecule. LCAO of two 1s-orbitals of H-atoms results in a 
binding and anti-binding MO. At the ground state both electrons pair in the binding σ-MO according to 
a σ-bound. 
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4 Results 
4.1 The type III secretion recognition protein YscU 
4.1.1 Design of the YscUC construct 
Initially, a suitable cytoplasmic YscU construct and the corresponding expression 
vector had to be designed for recombinant expression of YscU in E.coli cells. As 
YscU from Yersinia enterocolitca (Swiss-Prot. accession number Q56844) consists of 
an N-terminal trans-membrane and a C-terminal cytoplasmic domain (Sorg et al., 
2007), a prediction of the domain borders was made by using the topology prediction 
server PHOBIUS (Kall et al., 2004).  
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Figure 13: Topology and trans-membrane plot of YscU. The plot shows the probabilities of 
cytoplasmic (black) and TM helix (red) regions of YscU amino acid residues. 
The plot (Figure 13) shows four transmembrane helices in the N-terminal domain. 
The domain ends roughly at amino acid 208. Amino acids 211-354 were chosen to 
obtain a construct containing just YscUC. The corresponding yscUC gene was cloned 
into a pGEX-6P-1 vector using BamHI and AvaI restriction sites. Gene expression 
yields a GST-YscUC fusion protein, which is cleavable by the PreScission protease. 
For further experiments several variants of YscUC were generated by using site-
directed mutagenesis. 
RESULTS  46 
 
4.1.2 Preparation of YscUC 
For wild type YscUC and all YscUC variants a protein preparation scheme (Figure 14) 
was established to obtain sufficient amounts of pure protein. The protein preparation 
scheme is shown exemplarily for the wild type protein. 
 
Figure 14: Protein preparation scheme for YscUC and its variants. 
 
After cultivation and cell lysis of GST-YscUC producing E. coli cells (see Chapter 
3.3.1), the soluble supernatant was applied to glutathione sepharose for initial 
purification (Figure 15). GST-YscUC bound to the sepharose matrix, whereas 
unbound protein was removed by three washing steps. The GST fusion tag was 
cleaved off by adding PreScission protease and remained on the sepharose matrix, 
while YscUC had been eluted. The SDS-PAGE shows YscUC as a double band (10.5 
and 6.7 kDa) due to its autocleavage activity. Subsequently, YscUC containing 
fractions were dialyzed against IEC-buffer A to remove salt excess.  
The second purification step involved a cation exchange chromatography (MonoS 
10/100 column). Therefore, runs were optimized to two linear step gradients: 1st 0-
30 % IEC buffer B in 3 column volumes and 2nd 30-100% IEC buffer B in 1 column 
volume. After all protein solution had been applied to the column, YscUC was eluted 
(Figure 16) as a concentrated single peak in the first gradient at ~19 % IEC buffer B 
(~ 20 mS/cm). 
RESULTS  47 
 
 
Figure 15: SDS-gel of the GST affinity chromatography of YscUC. Autocleavage cleave YscUC into 
a 6.7 kDa N-terminal fragment and a 10.5 kDa C-terminal fragment. 
 
 
 
Figure 16: IEC elution profile (A) and corresponding SDS-gel (B) for YscUC. Pooled YscUC 
fractions are depicted as a red bar in the elution profile. 
 
As a final purification step gel permeation chromatography was performed using a 
Superdex 75 16/60 prep grade column (GE Healthcare). The elution profile (Figure 
17) shows a single peak at 71.5 mL. However, the peak is not fully symmetrical and 
shows a small tailing preceding the main peak. Sometimes the tailing also results in a 
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small additional peak containing YscUC. The YscUC elution volume corresponds to a 
mass of approximately 28 kDa compaired to a calibration curve (Figure 18). A 
subsequently performed DLS experiment showed a mono-disperse sample with a 
hydrodynamic radius of 2.36 nm (15.7 % polydispersity) and a calculated mass of 
25.1 kDa for YscUC. As both methods are based on the assumption of a globular 
shaped protein, the obtained masses are generally too high and therefore a 
monomer for YscUC is assumed. After validation of each fraction by SDS-PAGE, pure 
peak fractions were pooled and concentrated. For future experiments the protein was 
stored at -20 °C and aliquoted in vials containing 100 µL protein solution in GPC 
buffer at a concentration of 10-20 mg/mL. 
 
 
Figure 17: GPC elution profile (A) and corresponding SDS-gel (B) for YscUC. Pooled YscUC 
fractions are depicted as a red bar in the elution profile. The calculated mass of YscUC fram a GPC run 
is approximately 28 kDa. 
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Figure 18: Calibration curve of Superdex 75 16/60 and linear fit. The calibration run was 
performed using four different calibration proteins and a flow rate of 0.8 mL/min. Using the linear 
equation the molecular weight of YscUC (71.5 mL) corresponds to approximately 28 kDa. 
 
In summary, wild type YscUC and its variants were obtained in high purity and yield 
about 10-15 mg per L cell culture. However, SeMet – and 15N-labelled YscUC variants 
yielded only 3-5 mg/mL, due to the use of minimal medium. Successful SeMet 
incorporation was proven by mass spectroscopy (Figure 19). Each variant was 
checked for degradation, aggregation and freezing problems using DLS and SDS-
PAGE. All variants turned out to be stable even after long term storage. 
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Figure 19: MALDI-TOF-MS spectrum of purified SeMet YscUC N263A variant. [M+H] indicates the 
singly charged species, [M+2H] the doubly charged ion. The calculated molecular mass of fully SeMet-
labeled YscUC N263A is 17,378 kDa. The molecular mass also includes the N-terminal amino acids 
GPLGS that are remained on the protein after PreScission cleavage. 
 
4.1.3 Crystallization of YscUC 
Despite intensive screening using a variety of different protein concentrations, 
temperatures and additives, no crystals could be obtained for wild type YscUC. In 
contrast the YscUC N263A variant readily crystallized at 20 °C from a  crystallization 
solution containing 1.6 M (NH4)2SO4, 0.2 M NaCl and 0.1 M Hepes (pH 7.5). The 
octahedral shaped crystals (Figure 20) grew within 4 days. Optimization by varying 
the pH and the (NH4)2SO4 concentrations yielded in larger crystals with sizes up to 
450 µm x 450 µm x 800 µm. Under the same crystallization conditions crystals with 
the same habitus were obtained from the variants YscUC N263D and SeMet labelled 
YscUC N263A (Figure 20). All crystals were transferred into cryo-buffer containing 
reservoir buffer with 16 % (v/v) glycerol as cryo-protectant and flash-frozen at 100 K 
in liquid nitrogen. 
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Figure 20: Crystals of different YscUC variants. The scale bar corresponds to 200 µm. 
 
4.1.4 Data collection and space group determination 
Data collection for X-ray data sets of YscUC N263D and SeMet labelled YscUC N263A 
were performed at the ESRF beamline ID29 (Grenoble, France) and at the 
wavelength tuneable beamline X12 at the EMBL Outstation (Hamburg, Germany), 
respectively. For all isomorphous crystals a tetragonal symmetry with unit cell 
dimensions of a = b = 66.2 Å and c = 68.1 Å was determined. Analysis of systematic 
absence revealed missing reflections for the following conditions: along the 
crystallographic l axis with l=4n (00l, n=integer) and the h axis with h=2n (h00, 
n=integer). This indicated two possible enantiomorphous space groups: P41212 or 
P43212. Matthews probability analysis (Kantardjieff & Rupp, 2003; Matthews, 1968) 
revealed a packing parameter VM = 2.17 Å³/Da and a solvent content of 45 %. As 
only one molecule per asymmetric unit was estimated for unit cell content, an 
analysis for non crystallographic symmetries was not necessary. However, a self 
rotation function (Tong & Rossmann, 1997) was calculated (data not shown) and the 
data confirmed the Laue crystal class of 4/mmm. Data collection statistcs are 
summarized in Table 7 at the end of the Chapter 4.1.6. 
 
4.1.5 Fluorescence scan for MAD phasing 
As there was no appropriate protein model available for Molecular Replacement, 
phasing was achieved using anomalous dispersion at multiple wavelengths (MAD-
phasing). For this reason SeMet labelled YscUC N263A crystals were analyzed using 
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a fluorescence scan (Figure 21). The fluorescence spectrum near the selenium K-
edge revealed a protein specific absorption curve as a function of energy. The 
specific absorption edge provides the necessary information for finding f ’’ and f ’ and 
in turn the appropriate wavelength for measuring anomalous diffraction data. A 
standard fluorescence scan was performed between 12668 eV and 12728 eV and 
the following wavelengths were chosen for anomalous data set collection: 0.97853 Å 
(peak), 0.97892 Å (inflection point), 0.95369 Å (high energy remote) and 1.0000 Å 
(low energy remote). f ’’ and f ’ were calculated (Figure 22) from the fluorescence 
scan using the program CHOOCH (Evans & Pettifer, 2001).  
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Figure 21: X-ray fluorescence scan for SeMet labelled YscUC N263A. The scan was performed at 
the K absorption edge of selenium. The chosen wavelengths for MAD data collection are shown in the 
figure. 
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Figure 22: Plot of the YscUC N263A specific scattering factors f'' and f' as a function of the X-
ray energy. Specific values of f'' and f' at the inflection point and the peak are depicted in red and 
blue, respectively. The curves were calculated from the fluorescence scan using the program 
CHOOCH (Evans & Pettifer, 2001). 
 
4.1.6 Structure determination of YscUC  
 
Structure determination of YscUC N263A 
The solution of the selenium substructure, density modification and partial model 
building were done with the automated crystal structure determination platform: Auto-
Rickshaw (Panjikar et al., 2005) at the EMBL-Hamburg outstation. The system 
combines several macromolecular computer programs from the CCP4 suite 
(Collaborative Computational Project, Number 4, 1994) into an automated software 
pipeline solving macromolecular structures. Therefore, the platform allows for rapid 
analysis of structure solution and validation already at the synchrotron beamline. 
However, the process has to be carefully checked at different stages based on the 
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obtained output. The obtained initial electron density map revealed the positions of 
the selenium sites (Figure 23). The two, out of the four expected selenium, sites were 
sufficient to solve the structure. The resulting electron density was of sufficient quality 
to allow construction of an initial model using the program Arp/wARP (Morris et al., 
2003). In iterative cycles model building was carried out manually using COOT 
(Emsley & Cowtan, 2004) and refinement was completed using REFMAC5 
(Murshudov et al., 1997). 
 
 
Figure 23: Initial electron density map of SeMet YscUC N263A after density modification. The 
map is drawn at a contour level of 1.5 σ. The two detected selenium atom are depicted as orange 
spheres (A and B). 
 
Structure determination of YscUC N263D 
Using the program PHASER (McCoy et al., 2005) and the refined structure of SeMet 
labelled YscUC N263A as a phasing model, the structure of YscUC N263D was solved 
using the difference Fourier technique. Final model building was performed manually 
using COOT (Emsley & Cowtan, 2004) and refinement was completed using 
REFMAC5 (Murshudov et al., 1997). 
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Table 7: Data collection and refinement statistics. 
 SeMet-labeled YscUC N263A  
 
Data sets 
 
Peak 
 
Inflection 
High-
energy 
remote 
Low-energy 
remote 
 
YscUC N263D 
Data collection ststistics     
Beamline DESY X12 DESY X12 DESY X12 DESY X12 ESRF ID29 
Space group  P43212 P43212 P43212 P43212 P43212 
Unit cell dimensions  
   a (Å) 
   c (Å) 
 
66.2 
68.1 
 
66.2 
68.1 
 
66.2 
68.1 
 
66.3 
68.8 
 
66.5 
68.1 
Wavelength (Å)  0.97854 0.97893 0.95370 1.0000 0.9500 
Resolution (Å)  30.0-2.33 
(2.41-2.33) 
40.0-2.33 
(2.41-2.33) 
40.0-2.33 
(2.41-2.33) 
30.0-2.0 
(2.11-2.0) 
10.0-1.55 
(1.63-1.55) 
Mosaicity (°) 0.80 0.98 0.89 0.95 0.24 
Unique reflections  6910 (670) 6907 (663) 6920 (667) 10836 
(1517) 
21871 (3232) 
Completeness (%)  100 (99.9) 100 (100) 100 (100) 100 (100) 96.7 (99.9) 
Multiplicity  13.6 (12.0) 13.6 (12.6) 13.8 (13.3) 13.6 (13.6) 3.1 (3.1) 
I/σI 31.7 (8.2) 34.3 (8.8) 34.0 (9.5) 8.1 (2.2) 8.4 (4.8) 
Rmerge(%) 8.2 (31.5) 7.7 (29.8) 7.8 (31.0) 6.9 (35.2) 5.2 (15.1) 
Wilson B-factor (Å2) 39 39 38 25 19 
Solvent content (%) 45 45 45 45 45 
      
Refinement statistics      
Rcryst (%) 
Rfree (%) 
   22.1 
25.2 
20.0 
22.2 
Number of atoms  
   Protein 
   Solvent 
   Cl- 
    
1021 
56 
1 
 
1104 
135 
1 
r.m.s.d. from ideal 
Bond lengths (Å) / 
Bond angles (°) 
    
0.015 
1.701 
 
0.013 
1.502 
Ramachandran plot regions 
Favoured (%) 
Allowed (%) 
   
95.3 
4.7 
 
96.4 
3.6 
Average B-factor  
Protein (Å²) 
Solvent (Å²) 
Cl- (Å²) 
    
29.7 
35.5 
27.0 
 
20.2 
33.9 
21.9 
Values in parentheses refer to shell of highest resolution. Rfree test set size for YscU N263A 5% and for 
YscU N263D 3%. 
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4.1.7 Validation of the YscUC structures 
The final refinement statistic is given in Table 7. The quality of both protein models 
was checked regularly during refinement on the basis of the Rcryst/Rfree-values and 
geometric parameters during refinement. Both structures were refined to Rcryst/Rfree-
values of 22.1/25.3 % for SeMet YscUC N263A and 20.1/22.5 % for YscUC N263D, 
respectively. The protomers, present in the asymmetric unit cell together with solvent 
molecules, were well defined for the amino acid residues 222-342 in SeMet YscUC 
N263A and for amino acid residues 222-343 in YscUC N263D. The remaining N- and 
C-terminal amino acids were not traceable in the electron density map and probably 
flexible.  
Bond lengths and bond angles showed no significant deviations from standard 
structures (Engh & Huber, 1991). Validation of the torsion angles and an all-atom 
contact analysis were carried out using the programs RAMPAGE (Lovell et al., 2003) 
and MOLPROBITY (Davis et al., 2007). In both structure all residues grouped in the 
most favoured or allowed regions of the Ramachandran plot (Figure 24). 
 
Figure 24: Ramachandran plot of SeMet YscUC N263A and YscUC N263D. Favoured and allowed 
regions are coloured dark and light, respectively. Forbidden regions are shown in white. The plot was 
obtained using the RAMPAGE (Lovell et al., 2003) server. 
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Good agreement of protein model and its electron density was indicated by the real-
space correlation coefficient (Rupp, 2006), which was calculated using the program 
OVERLAPMAP (CCP4 suite, 1994). In Figure 25 the main chain coefficients were 
well defined for SeMet YscUC N263A, whereas the coefficients for YscUC N263D are 
generally weaker, especially at the N- and C-terminus, the loop connecting β strands 
2 and 3 and the loop connecting α-helix 2 and β strand 4. These weak coefficients 
are most likely a consequence of the rather harsh geometric restraints applied during 
refinement at high resolution. The B-factor analysis is also given in Figure 25 and 
agrees well with the correlation coefficient. As expected, higher B-factors are 
observed at the loop regions and at the termini. 
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Figure 25: Plot of main chain residuals of B-factors and real-space coefficient correlation. 
SeMet YscUC N263A and YscUC N263D are depicted in black and red, respectively. B-factor values 
are drawn as a full line and the real-space correlation coefficient is drawn as a dashed line. Secondary 
structure elements of SeMet YscUC N263A are drawn at the bottom. 
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4.1.8 Crystal structure of uncleaved YscUC  
The globular domain of uncleaved YscUC (Figure 26) consists of a central, five-
stranded, mixed β-sheet (I-V), surrounded by four α-helices (1-4). α-helix 3 is almost 
perpendicular to the strand orientation of the central β-sheet. The NPTH-cleavage 
motif forms a type II β-turn connecting β-strands I and II with position 263 located at 
the C-terminal end of β-strand I.  
The globular autocleavage domain is preceded by an extended N-terminal loop 
containing a well defined α-helix (α0) comprising residues 232-244. This helix forms 
an antiparallel interaction with helix 4 of a symmetry-related YscUC monomer in the 
crystal (see next Chapter). 
 
 
Figure 26: Ribbon plot of the monomer of YscUC N263A. The position of the mutation in the 
cleavage site is indicated by a red star (*). After cleavage YscUC is divided into an N-terminal and a C-
terminal half, shown in brown and green, respectively. The modified NPTH motif, as well as Arg314 
and Arg296, are depicted as ball-and-stick models. 
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4.1.9 Linker α-helix 0 is pinched due to crystal contacts 
The crystal structure packing for uncleaved YscUC was analysed using the PISA 
server (Protein interfaces, surfaces and assemblies service, (Krissinel & Henrick, 
2007)). The result shows two large and tight crystal interfaces I and II (823 and 
719 Å2) and one small (227 Å2) crystal interface III (Table 8). A detailed analysis of 
the interfaces (Figure 27) reveals strong interactions between α-helix 0 and α-helix 4 
in interface II and between the NPTH motif plus a loop, connecting α-helix 2 and β-
strand 3, in interface I. Obviously crystal contacts restricted the conformational 
freedom of α-helix 0 resulting in a well ordered and defined N-terminal part. In 
structure homologues of YscUC the linker region is probably flexible and thus the 
linker domain is traceable in the electron density. The NPTH loop is involved in the 
crystal interfaces I and III, explaining why crystallization of cleaved, wild type YscUC 
was not possible in this space group. 
 
Table 8: Crystal contacts of YscUC N263D. 
Name Symmetry operation Surface area 
[Å2] 
Interacting residues 
Molecule 1                      Molecule 2 
I -y,-x,-z+1/2 823 232-233, 236-237, 
239-240, 264-267, 
286, 288-291, 293, 
314, 317-319 
 
232-233, 236-237, 
239-240, 264-267, 
286, 288-291, 293, 
314, 317-319  
 
II -y+1/2,x-1/2,z-1/4 719 224-228, 273, 275-
276, 278-281, 325-
326, 328, 331-332, 
334-335, 338-339, 
342 
 
222-223, 226, 229-
231, 233-234, 237-
238, 240-242, 244-
247 
 
III x-1/2,-y-1/2,-z+1/4 227 265, 290, 293-294, 
296-297 
227-228, 328-329, 
331 
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Figure 27: Ribbon plot of the crystallization interfaces between YscUC monomers. Residues 
involved in interface interaction are drawn in red. The symmetry mate building (A) interface I is brown, 
- (B) interface II is blue and - (C) interface III is purple. 
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4.1.10 Structural basis for autocleavage of YscU 
Close inspection of the modified NPTH motif in isosteric variant YscUC N263D 
(DPTH, Figure 28 A) shows that the main-chain carbonyl of Asp263 is tightly locked 
into position via hydrogen bonds to the backbone nitrogen atoms of His266 and 
Ile267. This structural stiffness is enhanced by the peptide bond with Pro264. All 
main-chain dihedral angles of the DPTH residues fall in the allowed regions of the 
Ramachandran plot, indicating no obvious conformational strain of main-chain atoms. 
A salt bridge with the guanidinium group of Arg314 positions the side chain of Asp263 
above its main-chain carbonyl group. 
The ideal entry angle for a nucleophilic attack of a carbonyl group has been proposed 
to lie between 100° and 110°, and a distance betwee n nucleophile and electrophile of 
2.5 Å. (Bürgi, 1974; Bürgi, 1973) The corresponding angle of the YscUC N263D 
variant is 109° with an N-C distance of 2.8 Å. The β-amide nitrogen of Asn263 would 
therefore be ideally positioned for a nucleophilic attack. Furthermore this geometric 
arrangement favours a stabilizing orbital overlap (Figure 28 B), where the anti-binding 
σ*-molecular orbital (MO; see Chapter 3.10) of the CαAsn-NAsn bond interferes with the 
nascent binding σ-MO of the C(=O)-N-bond in native YscU. This entails a lowering of 
the activation energy that has to be applied for a new bond formation. 
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Figure 28: (A) Stereoview of the modified NPTH motif of YscUC N263D. The C-terminal and N-
terminal halves are shown in brown and green respectively. The isosteric Asp263 is optimally 
positioned (109°) for a nucleophilic attack, as ind icated by the red dashed line. Hydrogen bonds are 
indicated by black dashed lines. The (2FO-FC,αC) electron density map of the cleavage site is depicted 
at a contour level of 1.5 σ.  
(B) Orbital-model illustrating the stabilizing orbital overlap (circle). The anti-bonding σ* molecular 
orbital (MO) of the Cα-N bond in Asn263 (blue) interferes with the nascent bonding σ-MO of the C(=O) 
N-bond (red). 
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4.1.11 Cleavage does not affect the overall structure of wild-type YscUC  
Recombinantly produced wild-type YscUC is readily cleaved into a ~ 6.3 kDa 
N-terminal (α-helices 0-1 and β-strand I) and a ~10.5 kDa C-terminal (α-helices 2-4 
and β-strands II-V) fragment. The fragments, remain tightly linked, however, 
(Lavander et al., 2002) resulting in a single peak in gel-filtration chromatography (see 
Chapter 4.1.2). Cleavage of the wild-type protein thus does not cause significant 
overall structural rearrangements compared to the uncleaved YscUC variants. This 
was confirmed by 2D-NMR ([15N,1H]-HMQC) spectroscopy by comparing 15N-labelled 
wild-type and N263A YscUC (Figure 29). Overall, wild-type YscUC shows a good 
dispersion of the signals, characteristic for a folded globular conformation (Wüthrich, 
1986). An equally good dispersion of the signals is observed for N263A YscUC. The 
NMR-spectra of wild-type and N263A YscUC superimpose very well, with most peak 
positions being virtually identical and line-widths apparently unaffected. Cleaved and 
uncleaved YscU thus share the same overall structure with minor, but physiologically 
highly relevant, changes in and close to the NPTH motif.  
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Figure 29: [15N,1H]-HMQC NMR spectra of YscUC. The contour lines of wild-type YscUC are shown 
in orange, those of YscUC N263A in black. 
 
4.1.12 The role of conserved amino acids in YscUC cleavage in vitro 
Substituting the nucleophile Asn263 by alanine, aspartate and glutamine abolished 
autocleavage of YscU. While Asn263 is thus essential for YscU-autocleavage, the 
role of surrounding residues is less clear. A systematic mutational analysis of the 
NPTH motif revealed an active participation of Pro264 and His266 in YscU 
autocleavage (Figure 30 A and B), whereas Thr265 is not involved (Sorg et al., 2007). 
Substitution of Pro264 by alanine reduced cleavage of YscUC significantly, whereas 
substitution by glycine prevents cleavage altogether. Variant H266A showed a partial 
cleavage of YscUC. The structure of YscUC showed that two arginine residues 
(Arg296 and 314) flank the NPTH motif. Of these, Arg314 is highly conserved, while 
Arg296 is less conserved. Substituting Arg314 by alanine correspondingly reduced 
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cleavage partly whereas cleavage of variant R296A was unaffected. Interestingly, 
cleavage was entirely abrogated in the double variant H266A/R314A, suggesting a 
synergistic involvement of these residues in the mechanism of cleavage.  
 
Figure 30: Autocleveage of different YscUC variants expressed in E.coli. (A) Coomassie-stained 
15% SDS-PAGE analysis of cells producing various YscUC variants. (B)  Overexpressed cells 
analyzed by immunoblotting using an anti-YscUC antibody. (C) pH-dependent cleavage of YscUC-
variants. SDS-PAGE analysis of purified YscUC-variants incubated at different pH-values. 
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4.1.13 Cleavage of some autocleavage-deficient YscUC mutants is partially 
restored at high pH 
Autocleavage of the slow-cleaving variant P270A of the flagellar protein FlhBC (a 
homologue of YscUC) has previously been reported to be pH-dependent (Ferris et al., 
2005). YscUC variants N263D, P264G, P264A and H266A/R314A were therefore 
analysed at pH 9, 10 and 11 (Figure 30 C). In variant N263D, no cleavage was 
observed at higher pH-values, whereas P264G, P264A and H266A/R314A were 
partially cleaved only at elevated pH. These observations match the published data 
on FlhB P270A (Ferris et al., 2005), suggesting that the nucleophile Asn263 needs to 
be activated by deprotonation of its side chain amide group. 
 
Figure 31 Analysis of LcrV secretion by different yscU mutants. Total cell (TC) and supernatant 
(SN) fractions of corresponding in trans complemented Yersinia ∆yscU mutant bacteria analyzed by 
immunoblot with anti-LcrV antibodies. 
 
4.1.14 YscU mutants that are not cleaved in vitro do not export the LcrV 
translocator 
Next, the export of the LcrV protein in the corresponding Yersinia mutant strains was 
investigated. Secretion was not affected for wild-type YscU and the variants H266A, 
R314A and R296A, but is lost in variants N263A, N263D, N263Q, P264A, P264G, 
and H266A/R314A, as confirmed by an immunoblot of the supernatant (Figure 31). 
The LcrV secretion pattern is in excellent agreement with the data described above 
for in vitro autocleavage. 
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4.1.15 The T3SS injectisome needle length is influenced strongly by YscU 
mutations 
The influence of the YscU modifications on needle length was investigated by 
measuring needles from Y. enterocolitica ∆yscU mutant bacteria expressing the 
respective mutants in trans. Bacteria expressing wild-type yscU produced regulated 
needles of 69±10 nm. Similar needle lengths were measured for the YscU variants 
H266A (67±9nm), R314A (72±12nm), and R296A (76±11nm). In contrast, the length 
of needles in YscU variants N263A (125±40nm), N263D (143±51nm), P264A 
(112±42nm), and P264G (114±30nm) was increased and less regulated. Interestingly, 
YscU variants N263Q (80±16nm) and H266A/R314A (77±15nm) were regulated with 
a length distribution slightly larger than that of wild-type YscU (Figure 32). 
 
Figure 32: Needle length measurements of yscU mutant bacteria expressing the corresponding 
yscU alleles in trans from the pBAD promoter. Indicated are the median, the standard deviation 
(sd), and the number of needles measured (N). 
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4.2 The type III secretion apparatus protein YscV 
All work in this thesis concerning the T3S apparatus protein YscV (formally called 
LcrD) was undertaken using the natural variant YscV R619G (wild type Swiss-Prot. 
Accession number P0C2V3). Hence in this thesis the natural variant YscV R619G is 
regarded as “wild type”. 
4.2.1 Design of the YscVC construct 
Similar to YscU the T3S apparatus protein YscV can be divided into an N-terminal 
trans-membrane domain and a cytoplasmic C-terminal domain. An investigation of its 
primary sequence should reveal the potential domain borders suitable for creating an 
E. coli expression construct of the cytoplasmic domain. The analysis of the PHOBIUS 
plot (Figure 33) revealed six trans-membrane helices within the first 315 amino acid 
residues. A sharp increase in cytoplasmic probability at amino acid residue 322 
indicates the start of the cytoplasmic domain. Therefore, the yscVC gene (aa 322-
704) was cloned into a pGEX-6P-1 vector using EcoRI and AvaI restriction sites. 
Gene expression results in a GST-YscVC fusion protein, which is cleavable by the 
PreScission protease. For further experiments several variants of YscVC were 
produced using site-directed mutagenesis. 
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Figure 33: Topology and transmembrane plot of YscV. The plot shows the posterior probabilities of 
cytoplasmic (black) and TM helix (red) regions of YscV. 
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4.2.2 Preparation of YscVC 
A protein preparation scheme for YscVC and its variants was established producing 
sufficient amounts of pure protein for further experiments. The following preparation 
scheme (Figure 34) was used for all YscVC proteins. 
 
Figure 34: Protein preparation scheme for YscVC and its variants. 
 
Similarity to YscUC GST-YscVC was produced recombinantly in E. coli Tuner DE3 
cells (see Chapter 3.3.1). After cell lysis supernatant was applied to glutathione 
sepharose for initial purification. Unbound protein was removed within three washing 
steps and GST-YscVC was eluted with reduced glutathione in four steps (Figure 35). 
The GST fusion tag was cleaved off by adding PreScission protease. Cleavage was 
terminated by adding a protease inhibitor mix and subsequently applied to anion 
exchange chromatography. YscVC was eluted in a single peak within a linear gradient 
(0.1 M -1 M NaCl) at 35 % ion exchange buffer B (Figure 36). The GST fusion protein 
was detected in the flow-through fractions and in a small peak prior to YscVC main 
peak. Only weak upper bands were observed for the YscVC containing fractions on 
the SDS-gel (Figure 36). Mass spectrometric analysis of the first upper band revealed 
that contamination is caused by the presence of the chaperone GroEL bound to 
YscVC. 
 As the amount of contamination was minimal, the main peak fractions of YscVC were 
pooled and concentrated to 10-15 mg/mL. Finally, about 5-10 mg protein was 
obtained from 1 L cell culture. A ThermoFluor assay (see Chapter 3.4.8) for YscVC 
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revealed stabilizing conditions for YscVC at 0.1 M Tris pH 8.1 and 100-200 mM NaCl 
(not shown). Therefore, protein solutions were dialysed against IEC buffer A and 
concentrated prior to crystallization.  
 
Figure 35: SDS-gel of the affinity chromatography of YscVC. 
 
 
 
Figure 36: IEC elution profile (A) and corresponding SDS-gel (B) for YscVC. Pooled fractions of 
YscVC are depicted as a red bar in the elution profile. 
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4.2.3 Oligomerisation state of YscVC is ambiguous 
In order to get information on the oligomerisation state, YscVC was analyzed by 
dynamic light scattering. To remove aggregated protein and dust particles samples 
were filtered and centrifuged prior to measurement. As YscVC contains two cysteine 
residues, a second sample under reducing conditions (10 mM DTT) was also 
prepared. Table 9 shows a summary of the results obtained. Under both conditions 
the analysis revealed small amounts (up to 10 %) of aggregation, but the main peaks 
show an equal hydrodynamic radius indicating the absence of disulfide bonds. 
Assuming a globular shape of the protein, a potential molecular weight was 
calculated of about 116 kDa (YscVC: ~ 44 kDa). Due to the low sensitivity of this 
method, YscVC could therefore be a dimer or a trimer in solution.  
To exclude any influence of the cysteine residues and to confirm the DLS results a 
test with Ellman´s reagent was performed (see Chapter 3.4.5). The negative test 
(A412= 0.181) compared with YscVC (A412= 0.196) revealed only little increase of 
absorption, probably caused by the protein solution itself. This negative result 
confirms that both cysteine residues are not oxidized. 
Table 9: Results of dynamic light scattering measurements. 
Name Rhyd [nm] Polydispersity [%] MW [kDa] Mass [%] 
YscVC under oxidative conditions 
  
peak 1 
peak 2 
4.6 
21.3 
3.1 
5.7 
119 
4339 
94.0 
5.3 
YscVC under reductive conditions 
  
peak 1 
peak 2 
 
4.5 
17.2 
5.9 
9.4 
113 
2621 
89.5 
8.0 
 
For further investigation of the oligomerisation state an analytical GPC run was 
performed (oxidizing conditions) using a Superdex S200 16/60 prep grade column. 
However, the elution profile shows multiple peaks containing YscVC (Figure 37). The 
asymmetric peak (~ 48-60 mL) that is located close to the void volume indicates 
aggregated protein, which was also observed in the DLS experiment. The second 
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broad peak (~ 70 -96 mL) consists of at least two peaks with the same height, which 
could probably indicate dynamic changes in the oligomerisation state. 
 
 
Figure 37: GPC elution profile (A) and corresponding SDS-gel (B) for YscVC. 
 
From the GPC run it was not evident whether YscVC appeared as two distinct 
species or not. Therefore, an AF4 run with a coupled static light scattering experiment 
was performed (Figure 38). For this propose, volumes of 1.4 µL and 2.8 µL 
(7x10-4 g/mol) were injected into the separation channel. In both runs YscVC elutes in 
a broad peak similar to the GPC run. Analysis of the static light scattering experiment 
revealed increasing masses with progressing time. In the double concentrated run 
distinct plateaus are rising up at ~ 100, 126 and 210 kDa, which could be assigned to 
potential dimers, trimers and tetramers. However, the obtained results are only initial 
experiments indicating dynamic changes of several oligomerisation states. As YscV 
is supposed to be single species in the T3S apparatus, oligomerisation could be 
caused by the missing N-terminal domain. Therefore, further investigations of the 
oligomerisation state of YscVC were not performed. 
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Figure 38: AF4 run of YscVC with subsequent SLS analysis. Plot shows the UV absorbance 
(continuous line) and the molar mass (dashed line) as a function of time. Two runs were performed 
using 1.4 µL (red) and 2.8 µL (blue) YscVC solution (7x10-4 g/mol). The molar mass for distinct steps is 
measured as average. 
 
 
4.2.4 Crystallization of YscVC  
Although the dynamic oligomerisation problem could not be resolved, initial screening 
experiments were performed using a crystallization robot. Drop sizes were set to 
300 nL protein solution (10-15 mg/mL) and 300 nL reservoir solution. Screens were 
stored at 20 °C and controlled daily for protein cr ystals. After two days a shower of 
needle shaped crystals (Figure 39) was observed under several conditions (Table 10) 
containing either (NH4)2SO4 or MPD (2-methyl-2, 4-pentandiol) as precipitation agent. 
Izit staining of the crystals confirmed the presence of protein in the crystals. 
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Figure 39: Initial crystals of YscVC. Grown crystals under (A) NH4SO4 (JCSG Core suite III, E1) and 
(B) MPD (EasyExtal pHClear suite, G2) conditions as precipitation agent. In B crystals are stained with 
Izit. The scale bar is set to 300 µm. 
 
Table 10: Initial crystallization conditions of YscVC. 
Screen No. Condition 
EasyExtal AmSO4 suite G5 0.1 M Tris pH 8.5, 1 M (NH4)2SO4 
EasyExtal AmSO4 suite G6 0.05 M Sodium citrate, 1.2 M (NH4)2SO4, 3 % (w/v) 2-propanol 
EasyExtal pHClear suite G2 0.1 M Sodium acetate pH 5.0, 10 % (v/v) MPD 
EasyExtal pHClear suite H2 0.1 M Sodium acetate pH 5.0, 40 % (v/v) MPD 
EasyExtal pHClear suite H8 0.1 M Sodium acetate pH 5.0, 65 % (v/v) MPD 
JCSG Core suite II C2 0.1 M Hepes pH 7.5, 2 % (v/v) PEG 400, 2 M (NH4)2SO4 
JCSG Core suite III E1 0.1 M sodium cacodylate pH 6.0, 1.26 M (NH4)2SO4 
JCSG Core suite III E2 0.01 M CoCl2, 0.1 M Mes pH 6.5, 1.8 M (NH4)2SO4 
JCSG Core suite III E3 0.1 M Mes pH6.5, 10 % (v/v) dioxane, 1.6 M (NH4)2SO4 
 
All crystallization conditions were tested for their reproducibility and crystal 
optimization was performed to yield crystals suitable for X-ray analysis. However, 
most of the crystals were difficult to reproduce and optimization for more suitable 
crystals failed. During the refinement process one condition (0.1 M Tris pH 8.5, 1 M 
(NH4)2SO4 indicated the best for further refinement. Marcoseeding and additive 
screening yielded suitable crystals (Figure 40). However, the X-ray diffraction pattern 
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(BESSY BL14.1) range was limited to low resolution (Rmax=~20 Å). In order to get 
better diffracting crystals co-crystallization of YscVC was tried with its potential 
binding partner YscUC, but initial screening yielded only crystals of YscVC. 
 
Figure 40: (A) YscVC crystals after macro seeding and (B) corresponding diffraction image. 
Scale bar is set to 100 Å. The lower resolution ring is set to 12.2 Å. 
 
4.2.5 Limited proteolysis of YscVC created a new crystallization construct 
As all crystallization attempts for suitable YscVC crystals failed, limited proteolysis 
was performed resulting a new crystallization construct. The flagellar protein homolog 
FlhA from Salmonella thyphimurium yielded well diffracting crystals (Saijo-Hamano et 
al., 2005) after limited proteolysis, as well. Therefore, a similar experiment was 
performed for YscVC using trypsin, α-chymotrypsin- and endoproteinase GluC. The 
protein solution (final concentration 0.3 mg/mL) was incubated with the different 
proteases (1:200, w/w) at room temperature. Samples were collected at defined 
times and the cleavage reaction was terminated by adding a mixture of SDS-sample 
buffer and AEBSF (0.1 M; 4-(2-Aminoethyl) benzenesulfonyl fluoride). For storage 
samples were frozen at -20°C. 
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Figure 41: SDS-gel of a limited proteolysis of YscVC. 
 
Analysis of the limited proteolysis products (Figure 41) revealed an intensive band 
close to the 35 kDa marker for all three proteases. Using trypsin and α-chymotrypsin 
the band disappeared after 10 min, whereas with GluC the fragment was stable for 
over 2 h. Subsequent mass spectrometry analysis of a GluC gel band (10 min) 
revealed an intact C-terminus and an N-terminal fragment starting at amino acid 
residue 356. Further N-terminal sequencing analysis of the blotted trypsin digestion 
revealed the N-terminus starting at amino acid 360. 
 
4.2.6 Protein preparation and crystallization of YscVC356 
As a result of the limited proteolysis experiment, the new construct YscVC356 was 
cloned into a pGEX-6P-1 vector. Expression and purification were performed as 
described in Chapter 4.2.2. Analysis with DLS revealed a large Rhyd of 6.3 nm 
(polydispersity 15.3 %) and a test with Ellmann`s regent showed increasing 
absorption at 412 nm (negative test: A412= 0.181, YscVC356: A412= 0.364) indicating 
unspecific disulfide bonds. Therefore, a second dynamic light scattering experiment 
under reducing conditions (10 mM DTT) was performed and revealed a Rhyd (3.6 nm, 
polydispersity 17.8 %) which is the half Rhyd under oxidizing conditions. Further 
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preparations were then performed using 10 mM DTT as reducing agent. An analytical 
GPC run, which was performed under reducing conditions (10 mM DTT), showed a 
peak close to the void volume (44.4 mL) and a second one at 53.8 mL (Figure 42). 
The comparison of the elution volume to the molecular mass calibration curve (Figure 
43) indicated a Mr of 480 kDa, which corresponds to a YscVC dodecamer assuming a 
globular shape. 
 
Figure 42: (A) GPC elution profil of YscVC356 on a Superdex 200 16/60 column and (B) 
corresponding SDS gel. 
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Figure 43: Calibration curve of Superdex S200 16/60 and linear fit. The calibration run was 
performed using four different calibration proteins and a flow rate of 0.6 mL/min. 
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For initial crystallization screening the YscVC356 protein solution was reduced with 
buffered TCEP (tris(2-carboxyethyl)phosphine; final concentration 5 mM), as TECP is 
more resistant to oxidation in air as other reducing agents. Droplets were used with 
200 nL reservoir solution and 200 nL protein solution (24 and 12 mg/mL). After 2 d 
long needle shaped crystals (Figure 44) were obtained under several conditions 
(Table 11). X-ray suitable crystals were harvested from their mother liquid (SM I suite 
B12) and flash frozen in liquid nitrogen, as cryo protection was not necessary. 
However, X-ray diffraction patterns were not observed at our home-source. A mass 
spectrometric analysis of dissolved crystals was performed confirming YscVC356 to be 
present in the crystals (Figure 45). This was achvied by dissolved of crystals (washed 
before) in a 50 % (v/v) glycerol solution. Due to time constraints further crystal 
improvement and refinement has not yet been undertaken. 
 
 
Figure 44: Initial crystals of YscVC356 under reducing conditions. (A) SM I suite, B12; (B) SM I 
suite C1; (C) JCSG Core suite III, D1. The scal bar is set to 100 µm. 
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Table 11: Initial crystallization conditions for YscVC356. 
Screen No. Condition 
SM I suite B12 0.2 M NaCl; 0.1 M imidazole pH 8.0; 1 M (NH4)2HPO4 
SM I suite C1 0.1 M sodium actate pH 4.5; 1 M (NH4)2HPO4 
SM I suite G8 0.2 M Li2SO4*H2O; 0.1 M Ches pH 9.5; 1 M K/Na-tartrate*4H2O 
SM I suite G11 0.2 M NaCl; 0.1 M imidazole pH 8.0; 1 M K/Na-tartrate*4H2O 
JCSG Core suite III D1 1 M K/Na-tartrate; 0.2 M NaCl; 0.1 M imidazole pH 8.0 
JCSG Core suite III E4 1.6 M MgSO4; 0.1 M Mes pH 6.5 
JCSG Core suite IV G2 1 M K/Na-Tartrate; 0.1 M Mes pH 6.5 
JCSG Core suite III E2 0.01 M CoCl2, 0.1 M Mes pH 6.5, 1.8 M (NH4)2SO4 
JCSG Core suite III E3 0.1 M Mes pH6.5, 10 % (v/v) dioxane, 1.6 M (NH4)2SO4 
 
 
 
Figure 45: MALDI-TOF-MS spectrum of a dissolved crystal of YscVC356. [M+H] indicates the 
singly-charged species, [M+2H] the doubly-charged ion. The calculated molecular mass of YscVC356 
(including additional amino acid residues that remain on the protein after GST cleavage: GPLGSPEF) 
is 40,912 kDa. 
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4.3 Interaction analysis between YscUC and YscVC  
Analysis of the flagellar export apparatus proteins FlhA (corresponding to YscV) and 
FlhB (YscU) revealed interactions for full-length proteins and their cytoplasmic 
regions (Minamino & MacNab, 2000b; Zhu et al., 2002). Further interaction analysis 
by FRET measurement suggested an interaction for the latter, which is dominated by 
an electrostatic and/or hydrogen-bonding network (Zhu et al., 2002). To analyze the 
nature of this interaction in the Yersinia system, epitope scans were performed 
between YscUC and YscVC. For this purpose, corresponding 15mer peptides were 
produced and spotted on a cellulose membrane. The membranes were prepared and 
incubated with the corresponding proteins and antibodies. Used membranes were 
recycled for further experiments or evacuated in a shrink wrap film and stored at 
-20 °C. 
In the first analysis round interactions were identified and interaction sites were 
roughly located. Therefore two membranes were produced with peptide spots 
containing short sequences of YscUC and YscVC. The peptide spots were arranged 
as 15mers, which were shifted by three amino acid residues along the amino acid 
sequence (15/3 scan). To exclude unspecific interaction between peptide spots and 
GST, a background scan with GST was performed (Figure 46). The YscVC membrane 
revealed unspecific interactions for five peptide spots, whereas no unspecific 
interaction was detected for YscUC. All other membranes also showed no unspecific 
interactions. 
 
Figure 46: Background scans for YscVC (A) and YscUC (B). Membranes were incubated with GST 
to detected unspecific interactions. Peptide spots with unspecific interactions are marked by black 
arrows. 
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Only unspecific background spots and no specific interactions were observed 
between GST-YscUC and the YscVC peptides (Figure 47 A). However, the YscUC 
peptides (Figure 47 B), which were incubated with GST-YscVC, revealed interaction 
spots for peptides 18-21, 24-25, 32-34 and 43. The scan showed interaction spots 
with weak and stronger intensity providing information about binding affinity between 
peptide and protein. For precise analysis of the binding sites, areas around intensive 
spots (18-25 and 31-35) were scanned again using a 15/1 epitope scan. A finer 15/1 
scan for peptide 43 was not necessary, as the peptide is located at the C-terminal 
end of YscUC and the spot before showed no interaction at all. Furthermore, the 
intensive peptide spots 21, 24, 33 and 43 were analyzed in an alanine epitope scan 
revealing the binding potential of each amino acid residue between peptide and 
protein.  
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Figure 47: 15/3 epitope scans of YscVC (A) Unspecific interactions are marked with black arrows. 
15/3 epitope scans of YscUC (B) and corresponding sequence analysis (C). Interacting peptide 
sequences are highlighted in red. Peptides used for a 15/1 scan and an alanine scan are indicated 
with a coloured bar and square, respectively. 
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Figure 48: 15/1 and Ala-scans of YscUC peptides. Interacting peptide sequences are highlighted in 
red. Peptides used for a 15/1 scan and an alanine scan are indicated with a coloured bar and square, 
respectively. 
 
The analysis of the 15/1 epitope scan for peptides 18-25 (first round, light green bar) 
showed two main interaction areas including peptides 1-10 and 17-21 (Figure 48). 
Within these areas peptides share two common sequence sites: 271ILYKRG276 (1-10) 
and 281LVTFKYTDAQV292 (17-21). A further alanine scan analysis (Figure 48 and 
Figure 49) revealed important binding sequences as 271ILYKRx276 (1-10) and 
281LVTFKYxxxx292 (17-21) within the motifs. The second 15/1 scan for peptides 31-35 
(first round, brown bar) showed interactions with peptides 26-34 (Figure 48) with the 
common sequence site 312LARALYW318 and the alanine scan provided 312LxRxxx318 
(Figure 49) as important amino acid residues. For the last peptide 43 (orange) only 
an alanine scan was performed revealing the binding motif 337VLRWLxR343 (Figure 
49).  
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Finally, the epitope scan interaction analysis yielded four different peptide interaction 
sites for GST-YscUC. Within these sites an alanine scan revealed essential amino 
acids for binding of peptides. Transfer of the epitope scan results on the structure of 
YscUC are discussed in the next chapter. 
 
Figure 49: Ala-scans of YscUC peptides. Interacting peptide sequences are highlighted in red. 
Alanine exchanged amino acid residues, which showed no interaction, are underlined.  
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5 Discussion 
 
5.1 YscU - a type III secretion recognition protein 
YscU is one of five integral membrane proteins (YscR, -S, -T, -U, -V) building the 
T3SS export apparatus, which is likely to be located in the inner membrane ring of 
the basal body (Cornelis, 2006). Its autocleavable cytoplasmic domain plays a critical 
role in recognition of substrates during the export process (Sorg et al., 2007). To gain 
structural information about the T3S recognition protein YscU, the autocleaving 
cytoplasmic domain was intensely analyzed. For this purpose, a preparation scheme 
for YscUC was established yielding sufficient amounts of protein. Crystal structures of 
YscUC variants N263A and N263D were determined using multiple anomalous 
dispersion. The high resolution structure revealed the structural basis of YscUC 
autocleavage. Additionally, single-residue YscUC variants within the NPTH motif or its 
immediate vicinity were investigated with respect to their role in cleavage and needle-
length control. 
 
5.1.1 YscU is poised for autocatalytic cleavage 
The crystal structure of non-cleaving YscUC variant N263D (the asparagine 
nucleophile is replaced by the isosteric homologue aspartate) suggests that the side-
chain of Asn263 is positioned ideally for a nucleophilic attack and subsequent 
cleavage of wild-type YscUC. In N263D, the attack on its own carbonyl is prevented 
by the insufficient nucleophilicity of the Asp 263 carboxylate, despite its equivalent 
position. In N263Q, the nucleophilicity should be similar to that of asparagine. 
However, the longer and hence more flexible side chain disfavours the formation of a 
lactam ring in this variant, preventing cleavage of YscUC.  
YscUC autocleavage is crucially dependent on the positioning of the attacked 
carbonyl group of Asn263, which is part of the peptide bond to Pro264. Increasing the 
flexibility of the main chain correspondingly prevents cleavage in the variants P264A 
and P264G. As indicated above, cleavage is compromized in variants H266A and 
R314A, but entirely abrogated in H266A/R314A. Increasing the pH increases 
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cleavage, suggesting a role for both His266 and Arg314 in efficient autocleavage. By 
providing of a hydrogen bond, Arg314 most likely serves to optimally position the side 
chain of Asn263 allowing nucleophilic attack to occur at an angle of 109°. The role of 
His266 is, however, less clear. It may potentially mediate the abstraction of a proton 
from Asn263 either directly or by deprotonating bridging water molecule. A similar 
role has been proposed for a histidine residue during autosplicing of the DnaB mini-
intein (Ding et al., 2003). Thr265, as the only not fully conserved amino acid of the 
NPTH motif, does not appear to be involved directly in the cleavage reaction (Sorg et 
al., 2007; Zarivach et al., 2008). A preference for β-branched amino acids indicates a 
role in structurally stabilizing the type II turn (Gunasekaran et al., 1997) 
The results are supported by similar structural and functional data reported for the 
YscU homologues EscU from enteropatogenic E. coli, SpaS from Salmonella 
typhimurium (Zarivach et al., 2008), Spa40 from Shigella Flexneri (Deane et al., 
2008) and YscU from Yersinia pestis (Lountos et al., 2009). The crystal structures of 
the cleaved wild type EscU, as well as a number of EscU variants, were determined 
and correlated with in vivo cleavage experiments of full-length EscU (variants). Wild 
type YscUpestis, EscU, SpaS and Spa40 reveal unchanged tertiary structures of nicked 
proteins, concurring with our conclusion based on NMR-analysis of YscUC wild type 
and mutant (Figure 50).  
The only major differences concern YscUC variants H266A and R314A and their 
homologous variants in vivo in full-length EscU. Both YscUC variants show partial 
autocleavage in vitro and a wild type-like secretion of LcrV in vivo. EscU variant 
H265A is found to be fully autocleaved but secretion of T3S substrates is lost 
(Zarivach et al., 2008). EscU variant R313A, by contrast, remains uncleaved but 
again T3S substrates secretion is lost (Zarivach et al., 2008). A third EscU variant, 
R133T, is fully cleaved but retains normal effector secretion (Zarivach et al., 2008). 
Thus, despite a high level of structural conservation between YscU and EscU, some 
functional differences between the Yersina and EPEC T3SS may exist. The in vitro 
cleavage data on YscUC His266 variants would presumably implicate His265 in EscU 
in the asparagine-driven autocleavage reaction.  
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Figure 50: Structural overlay of YscUCN263D (2W0R) and YscUCpestis (2JLI). The cleaved N’PTH-
motif is depicted by an arrow. 
 
Based on structural and functional data the following autocleavage reaction 
mechanism is proposed (Figure 51). (i) The unique reaction geometry of YscU and its 
homologues is a prerequisite for the nucleophilic attack. The β-amide nitrogen, 
activated through proton abstraction by His266 or an intermediate water molecule, is 
optimally positioned to attack the electrophilic carbonyl carbon at an angle of 109° 
(108° in EscU). (ii) The tetrahedral reaction inter mediate is stabilized by hydrogen 
bonds to the backbone amides of His266 and Ile267. (iii) Protein cleavage gives rise 
to a labile succinimide, which is rapidly hydrolysed to yield a new C-terminal 
asparagine or iso-asparagine. 
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Figure 51: Structure-based model of succinimide-mediated cleavage of YscU. (I) His266 (or a 
His266-activated water molecule) abstracts a proton from the β-amide nitrogen of Asn262. The latter 
nucleophilically attacks the Asn262 carbonyl resulting in the rate-limiting tetrahedral intermediate (II). 
Cleavage of the peptide bond yields a labile C-terminal succinimide (III) which is hydrolysed to 
asparagine or iso-asparagine. 
 
The structure of YscUC also explains phenotypes of previously reported YscU 
variants. The strongly reduced export of the presumed inner rod protein YscI (in an 
yscPyscU mutant background) in the YscU variant Y317D implicates Tyr317 in 
interacting directly with YscI (Wood et al., 2008). Structurally, this strictly conserved 
residue is fully exposed at the surface of α-helix 3. Presumably, the introduction of a 
negative charge prevents interaction with YscI explaining the observed phenotype 
(Zarivach et al., 2008). The YscU variant G270N has been reported to cause the 
complete loss of T3S and YscU autocleavage (Riordan & Schneewind, 2008). 
Gly270, in the middle in β-strand II, is fully buried in the hydrophobic core of the 
domain. Replacing this residue by the significantly bulkier asparagine presumably 
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compromises folding or structure of the protein, resulting in degradation of this 
protein and consequently, a non-functional T3SS. 
 
5.1.2 Needle length in a non-cleavable YscU mutant is controlled even without 
YscP over-expression 
In vivo analyses reveal a new phenotype for the YscU variants N263Q and 
H266A/R314A. These variants do not undergo autocleavage in vitro. Corresponding 
bacterial mutants do not secrete the translocator LcrV that constitute the tip complex 
thus prevent pore formation. Their needles are, however, of normal size, although 
significantly less molecular ruler protein YscP is secreted compared to wild type 
bacteria (data not shown). In the YscU N263A mutant, wild type needle length could 
be restored only by YscP over-expression implying that YscU autocleavage inhibition 
diminishes YscP secretion losing control over needle length (Sorg et al., 2007). The 
phenotype observed here for the variants N263Q and H266A/R314A demonstrates 
that the loss of autocleavage may indeed affect the secretion of YscP and LcrV 
without relinquishing control over needle length. The fact that different phenotypes 
are observed for N263A and N263Q involving the same residue, may indicate that 
small amounts of YscP are sufficient to determine needle length but that a defined 
conformation of YscU also contributes. 
 
5.1.3 The flexible linker region is composed of two hinged α-helices 
A structural superposition of uncleaved YscUC variant N263A with EscUC (rmsd 1.3 Å 
for 94 common Cα atoms), SpaSC form Salmonella typhimurium (rmsd 1.0 Å for 80 
Cα atoms), and Spa40C from Shigella flexneri (rmsd 1.0 Å for 82 Cα atoms) reveals 
virtually identical folds for the cytoplasmic core region and the NPTH motifs, despite a 
low level of overall sequence identity (Figure 52). 
An obvious difference between YscUC and its homologues EscUC, SpaSC and 
Spa40C involves the proposed flexible linker (211-248) connecting the globular 
autocleavage domain to the N-terminal membrane-spanning four-helix bundle (Figure 
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52). In YscUC, amino acids 232-244 form a well-defined α-helix, which is not 
observed in the homologues structures except for uncleaved YscUCpestis (Lountos et 
al., 2009). In the crystal structure of YscUC, α-helix α0 is involved in a crystal contact 
to α-helix α4 of the next monomer. One of the crystal forms of EscUC additionally 
reveals an additionally α-helix (α-1) N-terminal of α0 (Zarivach et al., 2008). The 
presence of α-helix α0 confirms earlier predictions of the secondary structure for the 
flagellar protein FlhB (Fraser et al., 2003).  
 
Figure 52: (a) Structure-based sequence alignment of YscUC from Y. enterocolitica (Swiss-Prot. 
accession number Q56844) with FlhBC from S. thyphimurium (P40727), EscUC from E. coli (Q7DB59), 
SpaSC from S. thyphimurium (P40702), Spa40C from S. flexneri (Q6XVW1) and HcrUC from X. oryzae 
(Q5H6T1). The secondary structures are from YscUC N263D. Conserved amino acids are marked in 
bold letters on coloured backgrounds. Substituted residues in this study are indicated by a yellow 
background. Less conserved amino acids are also bold and coloured in blue.  
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(b) Stereoview YscUC variant N263D (green) superimposed on its wild-type homologues EscUC 
(blue), SpaSC (grey) and Spa40C (orange). Important positions are marked by a green sphere. 
 
The linker region is essential for T3S (Zarivach et al., 2008). Corresponding deletions 
232-236, 234-245 and 230-245 in EscU and the point mutation G235P (S236P in 
YscU) abolish the export of T3S substrates, despite intact autocleavage. Similar 
results have been obtained for the FlhB protein (Fraser et al., 2003). Mapping these 
mutations onto the structure of YscUC indicates that each would delete or kink α-helix 
α0, which presumably functions as a spacer element, separating the globular 
autocleavage domain from the inner membrane. Additionally, the helix could be 
involved in direct or indirect binding of other components.  
Small amino acids such as Gly229 and Gly248 in EscU are assumed to provide 
flexibility to the linker region (Zarivach et al., 2008). Substituting conserved Gly229 by 
proline in EscU (G230 in YscU and located N-terminal of α-helix α0) decreases the 
export of T3S substrates significantly. An equivalent substitution in Gly247 (G248P in 
YscU and located C-terminal of α0) also reduces the export of T3S substrates. 
Combining the structural information on YscUC and EscUC with the in vivo data 
suggests that YscU-like proteins are composed of three domains (Figure 55): A 
membrane-spanning N-terminal domain and a C-terminal, cytoplasmic, globular, 
autocleavage domain bridged by a flexible linker region that can switch from an 
extended to a partially α-helical conformation. This adaptable architecture of the 
linker allows for sufficient conformational freedom to enable interactions of the 
autocleavage domain with other components of the T3SS during its assembly. 
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Figure 53: Model of tripartite domain arrangement of YscU: The N-terminal, membrane-spanning 
domain is followed by a flexible linker region and a globular autocleavage domain. 
 
 
5.2 The inner membrane protein YscV 
The integral membrane protein YscV (~ 77.8 kDa) is the largest component within the 
T3S apparatus. It is composed of an N-terminal trans-membrane domain, which is 
predicted to contain at least six trans-membrane helices, and a ~ 43 kDa C-terminal 
cytoplasmic domain. For the flagellar homolog protein FlhA interaction has been 
shown between its cytoplasmic domain and the ATPase complex as well as the 
cytoplasmic domain of YscU (McMurry et al., 2004; Zhu et al., 2002). Thus, it has 
been proposed that YscV and YscU together build a platform for docking the ATPase-
substrate complex (Minamino et al., 2010). 
For structural characterization YscVC was produced as a GST fusion protein and a 
purification scheme was established yielding sufficient amounts of the cytoplasmic 
domain. However, the obtained protein was slightly contaminated with GroEL, a 
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chaperone that is required for proper protein folding. Consequently, it can be 
assumed that small amounts of YscVC are not well folded. Investigation of the 
oligomerization state by DLS and analytical GPC revealed a multimeric 
oligomerisation state that is not induced by disulfide bridges. Further analyses with 
AF4 and SLS indicate a dynamic oligomerisation (up to tetramers). In contrast to 
these results the flagellar homolog FlhAC was clearly observed as a monomer (Saijo-
Hamano et al., 2004). Besides, it has been proposed that export apparatus proteins 
have only a low copy number (one or maximal two) (Minamino et al., 2008; Van 
Arnam et al., 2004). Therefore the high oligomerisation state is probably the 
consequence of not properly folded protein due to the missing N-terminal part.  
Despite the tendency for oligomerisation, screening for YscVC protein crystals 
revealed several crystallization conditions that contain either MPD or (NH4)2SO4 as 
precipitant. However, X-ray suitable crystals showed only diffraction patterns within 
low resolution range. The obtained spots are narrowly spaced indicating huge cell 
dimensions and therefore probably less ordered crystals.  
Analog to FlhA, a limited proteolysis experiment revealed a shorter N-terminus 
confirming a linker region between the trans-membrane domain and a compact 
cytosolic domain (Minamino et al., 2010; Zhu et al., 2002). The resulting truncated 
variant YscVC356 has to be treated with reducing agents, as aggregation was 
observed under oxidizing conditions. YscVC356 seems to be well folded, as no 
chaperone contamination was observed. However, not a monomer but a single, 
highly oligomeric species (~480 kDa) was obtained as analyzed by GPC. 
Crystallization trials revealed several initial hits containing needle shaped crystals. 
However, X-ray investigations revealed no X-ray diffraction. Due to time constraints, 
a detailed crystal refinement could not be performed. But these results provide a 
good basis for further crystal improvement. 
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5.3 Interaction analysis between YscUC and YscVC 
An interaction between the flagellar cytoplasmic domains of FlhA and FlhB has been 
shown by affinity blotting and FRET analysis to be dominated by electrostatic and/or 
hydrogen-bonding within the potential interaction site (Zhu et al., 2002). In order to 
characterize the interaction between YscVC and YscUC, a peptide-based epitope 
scan was performed. Thereby, the cellulose anchored peptides mimic surface areas 
of the corresponding interaction partner. 
Initial experiments revealed interactions of YscUC peptides with YscVC protein, but 
not the other way around. This is probably due to the fact that amino acid residues, 
which are involved in the interaction, are often close to each other in the folded 
protein, which is not true for elongated sequences. Therefore, the epitope scan was 
not suitable to observe complex three dimensional interactions. In a second analysis 
round the located interaction sites were analyzed in detail by a 15/1 scan resulting in 
four possible binding peptides: 271ILYKRG276, 281LVTFKYTDAQV292, 312LARALYW318 
and 337VLRWLER343. 
By mapping the results on the structure of YscUC N263A, four distinct interacting 
regions (Figure 54) can be assigned: tip of β-strand 2 and the following loop, β-strand 
3 and the following loop and α-helices 3 and 4. All regions are located within the C-
terminal half of YscUC. The amino acid residues are accessible for solvents except β-
strand 3, which is mainly buried by α-helices 0. It can be assumed that the main part 
of β-strand 3 is solvent accessible, although α-helix 0 covers this site in the crystal 
structure. As it was shown (see Chapter 4.1.9), the linker is pinched in this position 
due to crystallization contacts. The alanine scan provided information of side chain 
contributions to the interaction between peptide and protein. Analysis of the side 
chain accessibility revealed several amino acid side chains, which are important for 
interaction in the epitope scan, but are buried in the crystal structure. This 
mismatching concerns mainly amino acids of β-strand 3 and the amino acids Ile271 
and Leu312. The differences indicate the limitation of this method, mimicking the 
surface of a β-strand. However, several complex structures show that peptides are 
able to form helical interaction surfaces (Okon et al., 2008). Therefore, one can 
conclude that the highly conserved α-helix 3 and the end of α-helix 4 are important 
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for binding YscVC to YscUC. However, this presumption has to be proved by further 
interaction experiments as well as docking experiments based on structural 
information of both potential binding partners. 
 
Figure 54: Proposed interaction regions between YscUC and YscVC. (A) Tertiary and (B) 
secondary structure of YscUC N263A. The proposed binding regions are colored in red. Side chains of 
underlined amino acid residues are accessible for solvents. However, analysis of the alanine epitope 
scan revealed several side chains as important for interaction, which are buried in the crystal structure 
(271ILYKRx276, 281LVTFKYxxxx292, 312LxRxxx318 and 337VLRWLxR343, underlined aa side chains are not 
solvent accessible). 
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6 Outlook 
Recently, several crystal structures of substrate specificity proteins belonging to the 
T3SS YscU protein family have been determined in its cleaved and uncleaved form 
(Deane et al., 2008; Lountos et al., 2009; Wiesand et al., 2009; Zarivach et al., 2008). 
The structural basis for autocleavage has been elucidated by analyzing several non-
cleavable mutants. All data confirm that autocleavage occurs immediately after 
recombinant expression in E. coli cells. However, natively purified full-length YscU 
showed also uncleaved YscU suggesting that the cleavage process is regulated 
(Sorg et al., 2007). For the flagellar system it has been proposed that autocleavage is 
regulated in a time-dependent manner by the protein itself, further proteins or 
external factors such as pH or inhibitory proteins. It still remains elusive how the 
cleavage event is regulated (Deane et al., 2010). Further, the structures reveal a 
linker region between trans-membrane and autocleavage domains. The proper 
function of the linker region is essential for secretion of both effectors and 
translocators. Nevertheless, it is unclear how the linker is involved in the secretion 
process. 
Besides functional questions concerning the structural parts, YscU has also been 
shown to be involved in several interactions including the ATPase regulator complex 
(YscK/L) and the proposed C-ring (YscQ) (Riordan & Schneewind, 2008). Further 
experiments have to be conducted to analyze the role of these interactions during 
secretion. Furthermore, it has been proposed that YscU and YscP together regulate 
the needle length by triggering the so-called “substrate specificity switch” (Edqvist et 
al., 2003). Investigations of the Shigella system revealed a direct interaction between 
Spa40C (YscUC) and a 40 amino acid residues stretch within the proposed T3S4 
(Type III secretion substrate specificity switch) region of Spa 32 (YscP) (Botteaux et 
al., 2008). Structural analysis would give further insights in the switching event.  
 
 
OUTLOOK  97 
 
During completion of this thesis the crystal structures of the cytoplasmic domain of 
FlhA and InvA (YscV homologues) have been determined (Saijo-Hamano et al., 
2010; Worrall et al., 2010). Both structures are composed of a linker region and four 
unique sub domains. The sub domains of FlhA are proposed to shuttle between an 
open and closed conformation. The first sub domain resembles an ATPase binding 
domain of the circadian clock system of cyanobacteria suggesting an anchor point for 
the ATPase (Saijo-Hamano et al., 2010). The first and second sub domain of InvA 
also exhibit structural similarity to the peripheral stalk of the A7V-type ATPase 
(Worrall et al., 2010). Therefore structural investigations of the complex between the 
ATPase YscN and YscVC would provide deeper insights in the secretion process. 
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Figure 55: Schematic representation of the Yersinia injectisome. HM, host cell membrane; IM, 
inner membrane; OM, outer membrane; PG, peptidoglycan. The C-ring is represented in dashed lines 
as information on this component is still scare. Colour code of different structural components 
corresponds to Ysc/Yop proteins in Table 12. 
 Table 12: Overview about Yersinia Injectisome proteins and their homolog’s. (Please note: This 
is not a complete list of all proteins involved in the T3SS!) 
Ysc/Yop kDa Function Contact T3S Homologues Flagellar Structure 
Structural Components of the Injectisome 
YopB 41.9 Translocator, pore YopD, LcrV SipB1, IpaB², EspD³ None No 
YopD 33.2 Translocator, pore YopB, LcrV SipC1, IpaC², EspB³ None No 
LcrV 37.5 Needle tip structure YopB, YopD  SipD1, IpaD², EspA³ None LcrV 
YscF 9.4 Needle subunit LcrV PrgI1, MxiH², EscF³ - MxiH, YscF 
YscC 67.1 Secretin, OM ring YscW, YscD InvG1, MxiD², EscC³ none EscC N-ter. 
YscD 46.7 Upper part of MS ring  YscC, YscJ PrgH1, MxiG², EscD³ - PrgH C-ter. 
YscJ 27.0 Lowerof the MS ring YscD PrgK1, MxiJ², EscJ³ FliF EscJ 
YscR 24.4 Export apparatus YscS, YscU InvL1, Spa24², EscR³  FliP No 
YscS 9.6 Export apparatus YscR SpaQ1, Spa9², EscS³ FliQ No 
YscT 28.4 Export apparatus - InvN1, Spa29², EscT³ FliR No 
YscU 40.3 Export apparatus 
YscR,YscV, 
N-ter YscP 
SpaS1, Spa40², EscU³ FlhB C-ter: Spa40 EscU, YscU 
YscV 77.8 Export apparatus YscU InvA1, MxiA², EscV³ FlhA No 
YscK 23.9 Docking of the ATPase to the C-ring YscQ MxiK² - No 
YscL 24.9 ATPase Regulator YscN, YscQ MxiN² FliH No 
YscN 47.8 ATPase  YscL, YscK InvC1, Spa47², EscN³ FliI FliI, EscN 
YscQ 34.4 Subunit of the C-ring YscK, YscL SpaO/InvK1 ,Spa33² FliN + FliM FliN/M, HrpQ4 
Important Proteins for Assembly 
YscP 57.4 
Molecular ruler and 
substrate specificity 
switch 
N-term with 
YscU C-ter InvJ
1
, Spa32² FliK No 
YscW 14.6 Pilotin for YscC YscC InvH1, MxiM² - 
MxiM 
PilP 
YscH 18 
Early export substrate. 
Not needed for needle 
assembly 
- PscH5 - No 
YscI 12.7 
Early export substrate. 
Needed for needle 
assembly. 
- - - No 
YscO 19 
Substrate export. 
Needed for needle 
assembly/T3S. 
- CT6706 - CT670 
Proteins listed are: 1, Salmonella thypimurium; 2, Shigella spp.; 3, Enteropathogenic Escherichia coli; 
4, Pseudomonas syringae; 5, Pseudomonas aeruginosa; 6, Chlamydia trachomatis 
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